Attached files

file filename
EX-32.1 - EXHIBIT 32.1 - Primerica, Inc.pri_exhibitx3212q14.htm
EX-31.2 - EXHIBIT 31.2 - Primerica, Inc.pri_exhibitx3122q14.htm
EX-31.3 - EXHIBIT 31.3 - Primerica, Inc.pri_exhibitx3132q14.htm
EX-31.1 - EXHIBIT 31.1 - Primerica, Inc.pri_exhibitx3112q14.htm
EXCEL - IDEA: XBRL DOCUMENT - Primerica, Inc.Financial_Report.xls

UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
 
FORM 10-Q
 
(Mark One)
ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the quarterly period ended June 30, 2014
OR
¨ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934
For the transition period from              to             
Commission File Number: 001-34680
 

Primerica, Inc.
(Exact name of registrant as specified in its charter)
 
Delaware
27-1204330
(State or other jurisdiction of
incorporation or organization)
(I.R.S. Employer
Identification No.)
 
 
1 Primerica Parkway
Duluth, Georgia
30099
(Address of principal executive offices)
(ZIP Code)
(770) 381-1000
(Registrant’s telephone number, including area code)
Not applicable.
(Former name, former address and former fiscal year, if changed since last report)
 
Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days.    ý  Yes    ¨   No
Indicate by check mark whether the registrant has submitted electronically and posted on its corporate Web site, if any, every Interactive Data File required to be submitted and posted pursuant to Rule 405 of Regulation S-T (§232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit and post such files).    ý  Yes    ¨  No
Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, or a smaller reporting company. See the definitions of “large accelerated filer,” “accelerated filer” and “smaller reporting company” in Rule 12b-2 of the Exchange Act.
Large accelerated filer
ý
Accelerated filer
¨
Non-accelerated filer
¨  (Do not check if a smaller reporting company)
Smaller reporting company
¨
Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act).    ¨  Yes    ý  No
Indicate the number of shares outstanding of each of the issuer’s classes of common stock, as of the latest practicable date.
Class
 
As of July 31, 2014
Common Stock, $0.01 Par Value
 
54,298,847 shares



TABLE OF CONTENTS
 
 
Page
 
 
 
 



i


PART I – FINANCIAL INFORMATION

ITEM 1. FINANCIAL STATEMENTS.

PRIMERICA, INC. AND SUBSIDIARIES
Condensed Consolidated Balance Sheets
 
June 30,
2014
 
December 31,
2013
 
(Unaudited)
 
 
 
(In thousands)
Assets
 
 
 
Investments:
 
 
 
Fixed-maturity securities available for sale, at fair value (amortized cost: $1,676,785 in 2014 and $1,663,022 in 2013)
$
1,804,163

 
$
1,755,712

Equity securities available for sale, at fair value (cost: $39,353 in 2014 and $32,592 in 2013)
50,436

 
39,894

Trading securities, at fair value (cost: $9,250 in 2014 and $13,025 in 2013)
9,236

 
12,991

Policy loans
28,378

 
26,806

Total investments
1,892,213

 
1,835,403

Cash and cash equivalents
150,621

 
149,189

Accrued investment income
17,874

 
18,127

Due from reinsurers
4,077,734

 
4,055,054

Deferred policy acquisition costs, net
1,293,974

 
1,208,466

Premiums and other receivables
175,680

 
175,789

Intangible assets, net (accumulated amortization: $67,473 in 2014 and $65,131 in 2013)
66,521

 
68,863

Income taxes
38,676

 
32,450

Other assets
298,597

 
282,780

Separate account assets
2,581,659

 
2,503,829

Total assets
$
10,593,549

 
$
10,329,950

Liabilities and Stockholders’ Equity
 
 
 
Liabilities:
 
 
 
Future policy benefits
$
5,180,013

 
$
5,063,103

Unearned premiums
1,236

 
1,802

Policy claims and other benefits payable
238,598

 
253,304

Other policyholders’ funds
336,902

 
337,977

Notes payable
374,506

 
374,481

Income taxes
137,797

 
105,885

Other liabilities
346,538

 
377,690

Payable under securities lending
93,569

 
89,852

Separate account liabilities
2,581,659

 
2,503,829

Commitments and contingent liabilities (see Commitments and Contingent Liabilities note)
 
 
 
Total liabilities
9,290,818

 
9,107,923

Stockholders’ equity:
 
 
 
Common stock ($0.01 par value; authorized 500,000 in 2014 and 2013; and issued 54,194 shares in 2014 and 54,834 shares in 2013)
542

 
548

Paid-in capital
447,949

 
472,633

Retained earnings
721,788

 
640,840

Accumulated other comprehensive income (loss), net of income tax:
 
 
 
Unrealized foreign currency translation gains (losses)
41,749

 
41,974

Net unrealized investment gains (losses):
 
 
 
Net unrealized investment gains not other-than-temporarily impaired
92,050

 
67,379

Net unrealized investment losses other-than-temporarily impaired
(1,347
)
 
(1,347
)
Total stockholders’ equity
1,302,731

 
1,222,027

Total liabilities and stockholders’ equity
$
10,593,549

 
$
10,329,950

See accompanying notes to condensed consolidated financial statements.


1


PRIMERICA, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Income - Unaudited
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands, except per-share amounts)
Revenues:
 
 
 
 
 
 
 
Direct premiums
$
576,740

 
$
568,391

 
$
1,144,945

 
$
1,129,295

Ceded premiums
(410,546
)
 
(417,450
)
 
(813,261
)
 
(828,054
)
Net premiums
166,194

 
150,941

 
331,684

 
301,241

Commissions and fees
132,039

 
117,182

 
258,970

 
229,455

Net investment income
21,681

 
21,027

 
43,280

 
44,243

Realized investment gains (losses), including other-than-temporary impairment losses
831

 
3,468

 
1,094

 
5,754

Other, net
10,385

 
10,872

 
20,430

 
21,247

Total revenues
331,130

 
303,490

 
655,458

 
601,940

Benefits and expenses:
 
 
 
 
 
 
 
Benefits and claims
72,412

 
64,322

 
147,604

 
133,138

Amortization of deferred policy acquisition costs
32,696

 
30,112

 
67,890

 
61,364

Sales commissions
67,364

 
57,638

 
132,485

 
112,686

Insurance expenses
28,192

 
26,513

 
56,694

 
52,026

Insurance commissions
3,881

 
4,132

 
7,964

 
8,354

Interest expense
8,552

 
8,793

 
17,159

 
17,588

Other operating expenses
42,293

 
45,030

 
83,089

 
90,694

Total benefits and expenses
255,390

 
236,540

 
512,885

 
475,850

Income from continuing operations before income taxes
75,740

 
66,950

 
142,573

 
126,090

Income taxes
26,469

 
23,782

 
49,816

 
44,787

Income from continuing operations
49,271

 
43,168

 
92,757

 
81,303

Income from discontinued operations, net of income taxes

 
322

 
1,595

 
1,032

Net income
$
49,271

 
$
43,490

 
$
94,352

 
$
82,335

 
 
 
 
 
 
 
 
Basic earnings per share:
 
 
 
 
 
 
 
Continuing operations
$
0.89

 
$
0.75

 
$
1.66

 
$
1.41

Discontinued operations

 
0.01

 
0.03

 
0.02

Basic earnings per share
$
0.89

 
$
0.76

 
$
1.69

 
$
1.43

 
 
 
 
 
 
 
 
Diluted earnings per share:
 
 
 
 
 
 
 
Continuing operations
$
0.89

 
$
0.73

 
$
1.66

 
$
1.37

Discontinued operations

 
0.01

 
0.03

 
0.02

Diluted earnings per share
$
0.89

 
$
0.74

 
$
1.69

 
$
1.39

 
 
 
 
 
 
 
 
Weighted-average shares used in computing earnings per share:
 
 
 
 
 
 
 
Basic
54,927

 
56,511

 
55,075

 
56,553

Diluted
54,950

 
57,849

 
55,097

 
58,127

 
 
 
 
 
 
 
 
Supplemental disclosures:
 
 
 
 
 
 
 
Total impairment losses
$
(221
)
 
$
(5
)
 
$
(370
)
 
$
(91
)
Impairment losses recognized in other comprehensive income before income taxes

 
4

 

 
19

Net impairment losses recognized in earnings
(221
)
 
(1
)
 
(370
)
 
(72
)
Other net realized investment gains (losses)
1,052

 
3,469

 
1,464

 
5,826

Realized investment gains (losses), including other-than-temporary impairment losses
$
831

 
$
3,468

 
$
1,094

 
$
5,754

Dividends declared per share
$
0.12

 
$
0.11

 
$
0.24

 
$
0.22

See accompanying notes to condensed consolidated financial statements.


2


PRIMERICA, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Comprehensive Income (Loss) - Unaudited
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Net income
$
49,271

 
$
43,490

 
$
94,352

 
$
82,335

Other comprehensive income (loss) before income taxes:
 
 
 
 
 
 
 
Unrealized investment gains (losses):
 
 
 
 
 
 
 
Change in unrealized holding gains (losses) on investment securities
20,792

 
(55,000
)
 
38,722

 
(57,500
)
Reclassification adjustment for realized investment (gains) losses included in net income
(578
)
 
(2,573
)
 
(766
)
 
(4,232
)
Foreign currency translation adjustments:
 
 
 
 
 
 
 
Change in unrealized foreign currency translation gains (losses)
8,444

 
(8,305
)
 
(233
)
 
(12,493
)
Total other comprehensive income (loss) before income taxes
28,658

 
(65,878
)
 
37,723

 
(74,225
)
Income tax expense (benefit) related to items of other comprehensive income (loss)
7,173

 
(20,256
)
 
13,277

 
(21,770
)
Other comprehensive income (loss), net of income taxes
21,485

 
(45,622
)
 
24,446

 
(52,455
)
Total comprehensive income (loss)
$
70,756

 
$
(2,132
)
 
$
118,798

 
$
29,880

See accompanying notes to condensed consolidated financial statements.


3


PRIMERICA, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Stockholders’ Equity - Unaudited
 
Six months ended June 30,
 
2014
 
2013
 
(In thousands)
Common stock:
 
 
 
Balance, beginning of period
$
548

 
$
564

Repurchases of common stock
(9
)
 
(29
)
Net issuance of common stock
3

 
10

Balance, end of period
542

 
545

Paid-in capital:
 
 
 
Balance, beginning of period
472,633

 
602,269

Share-based compensation
17,068

 
23,234

Net issuance of common stock
(3
)
 
(10
)
Repurchases of common stock
(41,150
)
 
(101,044
)
Repurchases of warrants

 
(68,399
)
Adjustments to paid-in capital, other
(599
)
 

Balance, end of period
447,949

 
456,050

Retained earnings:
 
 
 
Balance, beginning of period
640,840

 
503,173

Net income
94,352

 
82,335

Dividends
(13,404
)
 
(12,794
)
Balance, end of period
721,788

 
572,714

Accumulated other comprehensive income (loss):
 
 
 
Balance, beginning of period
108,006

 
169,410

Change in foreign currency translation adjustment, net of income tax expense (benefit) of $(8) in 2014 and $(164) in 2013
(225
)
 
(12,329
)
Change in net unrealized investment gains (losses) during the period, net of income taxes:
 
 
 
Change in net unrealized investment gains (losses) not-other-than temporarily impaired, net of income tax expense (benefit) of $13,285 in 2014 and $(21,598) in 2013
24,671

 
(40,114
)
Change in net unrealized investment losses other-than-temporarily impaired, net of income tax expense (benefit) of $0 in 2014 and $(8) in 2013

 
(12
)
Balance, end of period
132,452

 
116,955

Total stockholders’ equity
$
1,302,731

 
$
1,146,264

See accompanying notes to condensed consolidated financial statements.


4


PRIMERICA, INC. AND SUBSIDIARIES
Condensed Consolidated Statements of Cash Flows - Unaudited
 
Six months ended June 30,
 
2014
 
2013
 
(In thousands)
Cash flows from operating activities:
 
 
 
Net income
$
94,352

 
$
82,335

Adjustments to reconcile net income to cash provided by (used in) operating activities:
 
 
 
Change in future policy benefits and other policy liabilities
107,236

 
97,129

Deferral of policy acquisition costs
(146,313
)
 
(131,042
)
Amortization of deferred policy acquisition costs
67,890

 
61,364

Change in income taxes
14,496

 
(8,079
)
Realized investment (gains) losses, including other-than-temporary impairments
(1,094
)
 
(5,754
)
Gain from sale of business, net
(1,595
)
 

Accretion and amortization of investments
(1,009
)
 
(1,791
)
Depreciation and amortization
5,717

 
5,339

Change in due from reinsurers
(23,511
)
 
(8,697
)
Change in premiums and other receivables
(8,873
)
 
(13,284
)
Trading securities sold, matured, or called (acquired), net
3,721

 
(4,613
)
Share-based compensation
5,836

 
7,952

Change in other operating assets and liabilities, net
(46,399
)
 
(28,355
)
Net cash provided by (used in) operating activities
70,454

 
52,504

Cash flows from investing activities:
 
 
 
Available-for-sale investments sold, matured or called:
 
 
 
Fixed-maturity securities - sold
46,163

 
78,755

Fixed-maturity securities - matured or called
163,038

 
141,854

Equity securities
188

 
2,998

Available-for-sale investments acquired:
 
 
 
Fixed-maturity securities
(220,214
)
 
(78,054
)
Equity securities
(5,403
)
 
(93
)
Purchases of property and equipment and other investing activities, net
(4,177
)
 
(15,916
)
Proceeds from sale of business
3,000

 

Cash collateral received (returned) on loaned securities, net
3,717

 
(53,655
)
Sales (purchases) of short-term investments using securities lending collateral, net
(3,717
)
 
53,655

Net cash provided by (used in) investing activities
(17,405
)
 
129,544

Cash flows from financing activities:
 
 
 
Dividends paid
(13,404
)
 
(12,794
)
Common stock repurchased
(41,159
)
 
(101,073
)
Warrants repurchased

 
(68,399
)
Excess tax benefits on share-based compensation
3,792

 
7,179

Payments of deferred financing costs
(403
)
 

Net cash provided by (used in) financing activities
(51,174
)
 
(175,087
)
Effect of foreign exchange rate changes on cash
(443
)
 
(1,090
)
Change in cash and cash equivalents
1,432

 
5,871

Cash and cash equivalents, beginning of period
149,189

 
112,216

Cash and cash equivalents, end of period
$
150,621

 
$
118,087

See accompanying notes to condensed consolidated financial statements.


5


PRIMERICA, INC. AND SUBSIDIARIES
Notes to Condensed Consolidated Financial Statements Unaudited

(1) Description of Business, Basis of Presentation, and Summary of Significant Accounting
Policies
Description of Business. Primerica, Inc. (the "Parent Company") together with its subsidiaries (collectively, "we", "us" or the "Company") is a leading distributor of financial products to middle income households in the United States and Canada. We assist our clients in meeting their needs for term life insurance, which we underwrite, and mutual funds, annuities and other financial products, which we distribute primarily on behalf of third parties. Our primary subsidiaries include the following entities: Primerica Financial Services, Inc. ("PFS"), a general agency and marketing company; Primerica Life Insurance Company ("Primerica Life"), our principal life insurance company; Primerica Financial Services (Canada) Ltd., a holding company for our Canadian operations, which includes Primerica Life Insurance Company of Canada ("Primerica Life Canada") and PFSL Investments Canada Ltd. ("PFSL Investments Canada"); and PFS Investments, Inc. ("PFS Investments"), an investment products company and broker-dealer. Primerica Life, domiciled in Massachusetts, owns National Benefit Life Insurance Company ("NBLIC"), a New York insurance company.
We capitalized Peach Re, Inc. ("Peach Re"), a special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life, and Primerica Life ceded to Peach Re certain level premium term life insurance policies pursuant to a coinsurance agreement (the "Peach Re Coinsurance Agreement") effective March 31, 2012.
In June 2014, we established Vidalia Re, Inc. ("Vidalia Re") as a special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life. Vidalia Re and Primerica Life entered into a coinsurance agreement whereby Primerica Life ceded to Vidalia Re certain level premium term life insurance policies (the "Vidalia Re Coinsurance Agreement") effective July 31, 2014.
Basis of Presentation. We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America ("U.S. GAAP"). These principles are established primarily by the Financial Accounting Standards Board ("FASB"). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions that affect financial statement balances, revenues and expenses and cash flows, as well as the disclosure of contingent assets and liabilities. Management considers available facts and knowledge of existing circumstances when establishing the estimates included in our financial statements.
The accompanying unaudited condensed consolidated financial statements contain all adjustments, generally consisting of normal recurring accruals, which are necessary to fairly present the balance sheets as of June 30, 2014 and December 31, 2013, the statements of income and comprehensive income (loss) for the three and six months ended June 30, 2014 and 2013, and the statements of stockholders' equity and cash flows for the six months ended June 30, 2014 and 2013. Results of operations for interim periods are not necessarily indicative of results for the entire year or of the results to be expected in future periods.
These unaudited condensed consolidated financial statements have been prepared pursuant to the rules and regulations of the Securities and Exchange Commission ("SEC"). Certain information and note disclosures normally included in annual financial statements prepared in accordance with U.S. GAAP have been condensed or omitted pursuant to those rules and regulations, although the Company believes that the disclosures made are adequate to make the information not misleading. These unaudited condensed consolidated financial statements should be read in conjunction with the consolidated financial statements and notes thereto that are included in our Annual Report on Form 10-K for the year ended December 31, 2013 ("2013 Annual Report").
Use of Estimates. The most significant items that involve a greater degree of accounting estimates and actuarial determinations subject to change in the future are the valuation of investments, deferred policy acquisition costs ("DAC"), liabilities for future policy benefits and unpaid policy claims, and income taxes. Estimates for these and other items are subject to change and are reassessed by management in accordance with U.S. GAAP. Actual results could differ from those estimates.
Consolidation. The accompanying unaudited condensed consolidated financial statements include the accounts of the Company and those entities required to be consolidated under applicable accounting standards. All material intercompany profits, transactions, and balances among the consolidated entities have been eliminated.


6


Reclassifications. Certain reclassifications have been made to prior-period amounts to conform to current-period reporting classifications. These reclassifications had no impact on net income or total stockholders' equity and were primarily related to discontinued operations. See Note 2 (Discontinued Operations) for more information.
Subsequent Events. The Company has evaluated subsequent events for recognition and disclosure for occurrences and transactions after the date of the unaudited condensed consolidated financial statements dated as of June 30, 2014.
Significant Accounting Policies. All significant accounting policies remain unchanged from the 2013 Annual Report.
New Accounting Principles. In May 2014, the FASB issued ASU No. 2014-09, Revenue from Contracts with Customers (Topic 606) (“ASU 2014-09”). ASU 2014-09 clarifies the principles for recognizing revenue by establishing the core principle that an entity should recognize revenue to depict the transfer of goods or services to customers in an amount that reflects the consideration to which the entity expects to be entitled in exchange for those goods or services. ASU 2014-09 also requires additional disclosure about the nature, amount, timing and uncertainty of revenue that is recognized. Insurance contracts are specifically excluded from the scope of ASU 2014-09 and therefore revenue from our insurance product lines will not be affected by the new standard. The amendments in ASU 2014-09 are effective retrospectively for the Company beginning in fiscal year 2017. Early adoption is not permitted. While we are still in the process of evaluating the guidance in ASU 2014-09, we do not expect it will have a material impact on our consolidated financial statements.
Future Application of Accounting Standards. Recent accounting guidance not discussed is not applicable, is immaterial to our financial statements, or did not or will not have an impact on our business.

(2) Discontinued Operations
In January 2014, NBLIC sold the assets and liabilities of its short-term statutory disability benefit insurance business ("DBL") to AmTrust North America, Inc. and its affiliates (the "buyer"). As part of the sale agreement, the buyer assumed all liabilities for DBL insurance policies. In addition, NBLIC transferred the assets held in support of DBL's insurance liabilities and all other premium-related assets and liabilities to the buyer as of January 1, 2014. The results of DBL's operations from January 1, 2014 forward were also transferred to the buyer. NBLIC received cash proceeds from the sale of $3.0 million and recognized a pre-tax gain on the sale of approximately $2.5 million, which comprised income from discontinued operations before income taxes in our results of operations for the six months ended June 30, 2014.
We no longer have significant continuing involvement in the operations of DBL, and its direct cash flows have been eliminated from our ongoing operations. As a result, beginning in the first quarter of 2014, the results of operations for DBL have been reported in discontinued operations for all periods presented in our unaudited condensed consolidated statements of income. The results of operations and the carrying values of the assets and liabilities related to DBL were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Total revenues from discontinued operations
$

 
$
8,817

 
$

 
$
18,812

Income from discontinued operations before income taxes

 
496

 
2,454

 
1,588

Provision for income taxes

 
174

 
859

 
556

Income from discontinued operations, net of income taxes
$

 
$
322

 
$
1,595

 
$
1,032

 
June 30, 2014
 
December 31, 2013
 
(In thousands)
Premiums and other receivables
$

 
$
6,439

Future policy benefits

 
5,047

Other liabilities

 
1,197




7


(3) Segment Information
We have two primary operating segments — Term Life Insurance and Investment and Savings Products. We also have a Corporate and Other Distributed Products segment. The results of operations for DBL were previously reported in our Corporate and Other Distributed Products segment and have been reclassified into discontinued operations as discussed in Note 2 (Discontinued Operations).
Total assets by segment were as follows:
 
June 30,
2014
 
December 31,
2013
 
(In thousands)
Assets:
 
 
 
Term life insurance segment
$
6,984,354

 
$
6,783,194

Investment and savings products segment
2,793,243

 
2,699,000

Corporate and other distributed products segment
815,952

 
847,756

Total assets
$
10,593,549

 
$
10,329,950

The Investment and Savings Products segment includes assets held in separate accounts. Excluding separate accounts, the Investment and Savings Products segment assets were approximately $212.2 million and $195.8 million as of June 30, 2014 and December 31, 2013, respectively.
Results of continuing operations by segment were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Revenues:
 
 
 
 
 
 
 
Term life insurance segment
$
184,366

 
$
169,182

 
$
367,346

 
$
337,016

Investment and savings products segment
128,148

 
113,361

 
251,418

 
222,083

Corporate and other distributed products segment
18,616

 
20,947

 
36,694

 
42,841

Total revenues
$
331,130

 
$
303,490

 
$
655,458

 
$
601,940

Income (loss) from continuing operations before income taxes:
 
 
 
 
 
 
 
Term life insurance segment
$
55,070

 
$
51,897

 
$
102,274

 
$
97,023

Investment and savings products segment
36,048

 
27,488

 
70,075

 
53,841

Corporate and other distributed products segment
(15,378
)
 
(12,435
)
 
(29,776
)
 
(24,774
)
Total income from continuing operations before income taxes
$
75,740

 
$
66,950

 
$
142,573

 
$
126,090

See “Management's Discussion and Analysis of Financial Condition and Results of Operations” included elsewhere in this report for more information regarding our operating segments.


8


Long-lived assets — primarily tangible assets reported in Other assets in our unaudited condensed consolidated balance sheets — and results of continuing operations by country were as follows:
 
June 30,
2014
 
December 31,
2013
 
(In thousands)
Long-lived assets by country:
 
 
 
United States
$
26,148

 
$
24,413

Canada
654

 
637

Total long-lived assets
$
26,802

 
$
25,050

 
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Revenues by country:
 
 
 
 
 
 
 
United States
$
270,923

 
$
246,650

 
$
533,127

 
$
486,023

Canada
60,207

 
56,840

 
122,331

 
115,917

Total revenues
$
331,130

 
$
303,490

 
$
655,458

 
$
601,940

Income from continuing operations before income taxes by country:
 
 
 
 
 
 
 
United States
$
56,619

 
$
49,565

 
$
105,532

 
$
92,604

Canada
19,121

 
17,385

 
37,041

 
33,486

Total income from continuing operations before income taxes
$
75,740

 
$
66,950

 
$
142,573

 
$
126,090


(4) Investments
The period-end cost or amortized cost, gross unrealized gains and losses, and fair value of available-for-sale fixed-maturity and equity securities follow:
 
June 30, 2014
 
Cost or
amortized
cost
 
Gross
unrealized
gains
 
Gross
unrealized
losses
 
Fair value
 
(In thousands)
Securities available for sale, carried at fair value:
 
 
 
 
 
 
 
Fixed-maturity securities:
 
 
 
 
 
 
 
U.S. government and agencies
$
9,733

 
$
557

 
$
(53
)
 
$
10,237

Foreign government
119,450

 
9,627

 
(1,133
)
 
127,944

States and political subdivisions
35,196

 
2,492

 
(198
)
 
37,490

Corporates
1,238,683

 
104,705

 
(3,261
)
 
1,340,127

Mortgage- and asset-backed securities
273,723

 
15,185

 
(543
)
 
288,365

Total fixed-maturity securities(1)
1,676,785

 
132,566

 
(5,188
)
 
1,804,163

Equity securities
39,353

 
11,483

 
(400
)
 
50,436

Total fixed-maturity and equity securities
$
1,716,138

 
$
144,049

 
$
(5,588
)
 
$
1,854,599

____________________
(1) 
Includes approximately $2.1 million of other-than-temporary impairment losses related to corporates and mortgage- and asset-backed securities recognized in accumulated other comprehensive income.


9


 
December 31, 2013
 
Cost or
amortized
cost
 
Gross
unrealized
gains
 
Gross
unrealized
losses
 
Fair value
 
(In thousands)
Securities available for sale, carried at fair value:
 
 
 
 
 
 
 
Fixed-maturity securities:
 
 
 
 
 
 
 
U.S. government and agencies
$
8,696

 
$
485

 
$
(127
)
 
$
9,054

Foreign government
111,610

 
7,512

 
(2,766
)
 
116,356

States and political subdivisions
32,308

 
1,860

 
(468
)
 
33,700

Corporates
1,240,100

 
84,545

 
(11,931
)
 
1,312,714

Mortgage- and asset-backed securities
270,308

 
14,610

 
(1,030
)
 
283,888

Total fixed-maturity securities(1)
1,663,022

 
109,012

 
(16,322
)
 
1,755,712

Equity securities
32,592

 
7,935

 
(633
)
 
39,894

Total fixed-maturity and equity securities
$
1,695,614

 
$
116,947

 
$
(16,955
)
 
$
1,795,606

____________________
(1) 
Includes approximately $2.1 million of other-than-temporary impairment losses related to corporates and mortgage- and asset-backed securities recognized in accumulated other comprehensive income.
The net effect on stockholders’ equity of unrealized gains and losses on investments was as follows:
 
June 30,
2014
 
December 31,
2013
 
(In thousands)
Net unrealized investment gains (losses) including foreign currency translation adjustment and other-than-temporary impairments:
 
 
 
Fixed-maturity and equity securities
$
138,461

 
$
99,992

Currency swaps
50

 
72

Foreign currency translation adjustment
1,032

 
1,523

Other-than-temporary impairments
2,072

 
2,072

Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments
141,615

 
103,659

Deferred income taxes
(49,565
)
 
(36,280
)
Net unrealized investment gains excluding foreign currency translation adjustment and other-than-temporary impairments, net of tax
$
92,050

 
$
67,379

We also maintain a portfolio of fixed-maturity securities that are classified as trading securities. The carrying values of the fixed-maturity securities classified as trading securities were approximately $9.2 million and $13.0 million as of June 30, 2014 and December 31, 2013, respectively.
All of our available-for-sale mortgage- and asset-backed securities represent variable interests in variable interest entities ("VIEs"). We are not the primary beneficiary of these VIEs because we do not have the power to direct the activities that most significantly impact the entities’ economic performance. The maximum exposure to loss as a result of our involvement in these VIEs equals the carrying value of the securities.
As required by law, we have investments on deposit with governmental authorities and banks for the protection of policyholders. The fair values of investments on deposit were approximately $19.8 million and $18.4 million as of June 30, 2014 and December 31, 2013, respectively.
We participate in securities lending transactions with broker-dealers and other financial institutions to increase investment income with minimal risk. We require minimum collateral on securities loaned equal to 102% of the fair value of the loaned securities. We accept collateral in the form of securities, which we are not able to sell or encumber, and to the extent the collateral declines in value below 100%, we require additional collateral from the borrower. Any securities collateral received is not reflected on our balance sheet. We also accept collateral in the form of cash, all of which we reinvest. For loans involving unrestricted cash collateral, the collateral is reported as an asset with a corresponding liability representing our obligation to return the collateral. We continue to carry the loaned securities as invested assets on our balance sheet during the terms of the loans, and we do not report them as sales. Cash collateral received and reinvested was approximately $93.6 million and $89.9 million as of June 30, 2014 and December 31, 2013, respectively.


10


The scheduled contractual maturity distribution of the available-for-sale fixed-maturity portfolio at June 30, 2014 follows:
 
June 30, 2014
 
Amortized cost
 
Fair value
 
(In thousands)
Due in one year or less
$
105,256

 
$
108,780

Due after one year through five years
548,289

 
606,371

Due after five years through 10 years
706,178

 
751,242

Due after 10 years
43,339

 
49,405

 
1,403,062

 
1,515,798

Mortgage- and asset-backed securities
273,723

 
288,365

Total fixed-maturity securities
$
1,676,785

 
$
1,804,163

Expected maturities may differ from scheduled contractual maturities because issuers of securities may have the right to call or prepay obligations with or without call or prepayment penalties.
Investment Income. The components of net investment income were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Fixed-maturity securities
$
20,454

 
$
22,648

 
$
41,486

 
$
45,858

Equity securities
471

 
292

 
856

 
564

Policy loans and other invested assets
398

 
327

 
786

 
647

Cash and cash equivalents
68

 
73

 
121

 
161

Market return on deposit asset underlying 10% coinsurance agreement
1,490

 
(1,061
)
 
2,443

 
(498
)
Gross investment income
22,881

 
22,279

 
45,692

 
46,732

Investment expenses
(1,200
)
 
(1,252
)
 
(2,412
)
 
(2,489
)
Net investment income
$
21,681

 
$
21,027

 
$
43,280

 
$
44,243

The components of net realized investment gains (losses) as well as details on gross realized investment gains and losses and proceeds from sales or other redemptions were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Net realized investment gains (losses):
 
 
 
 
 
 
 
Gross gains from sales
$
838

 
$
3,022

 
$
1,181

 
$
4,755

Gross losses from sales
(39
)
 
(448
)
 
(45
)
 
(451
)
Other-than-temporary impairment losses
(221
)
 
(1
)
 
(370
)
 
(72
)
Gains (losses) from bifurcated options
253

 
895

 
328

 
1,522

Net realized investment gains (losses)
$
831

 
$
3,468

 
$
1,094

 
$
5,754

Supplemental information:
 
 
 
 
 
 
 
Gross realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings
$
578

 
$
2,573

 
$
766

 
$
4,232

Tax expense (benefit) associated with realized investment gains (losses) reclassified from accumulated other comprehensive income into earnings
$
202

 
$
901

 
$
268

 
$
1,481

Proceeds from sales or other redemptions
$
96,511

 
$
145,014

 
$
209,389

 
$
223,607

Other-Than-Temporary Impairment. We conduct a review each quarter to identify and evaluate impaired investments that have indications of possible other-than-temporary impairment ("OTTI"). An investment in a debt or equity security is impaired if its fair value falls below its cost. Factors considered in determining whether an unrealized loss is temporary include the length of time and extent to which fair value has been below cost, the


11


financial condition and near-term prospects for the issue, and our ability and intent to hold the investment for a period of time sufficient to allow for any anticipated recovery, which may be maturity for fixed-maturity securities or within a reasonable period of time for equity securities. For additional information, see Note 3 (Investments) to the consolidated financial statements in our 2013 Annual Report.
Investments in fixed-maturity and equity securities with a cost basis in excess of their fair values were approximately $202.7 million and $454.2 million as of June 30, 2014 and December 31, 2013, respectively.
The following tables summarize, for all securities in an unrealized loss position, the aggregate fair value and the gross unrealized loss by length of time such securities have continuously been in an unrealized loss position:
 
June 30, 2014
 
Less than 12 months
 
12 months or longer
 
Fair value
 
Unrealized
losses
 
Number
of
securities
 
Fair value
 
Unrealized
losses
 
Number
of
securities
 
(Dollars in thousands)
Fixed-maturity securities:
 
 
 
 
 
 
 
 
 
 
 
U.S. government and agencies
$

 
$

 
 
$
897

 
$
(53
)
 
2
Foreign government
1,425

 
(22
)
 
5
 
24,387

 
(1,111
)
 
39
States and political subdivisions
3,296

 
(118
)
 
4
 
3,193

 
(80
)
 
3
Corporates
32,559

 
(333
)
 
37
 
71,932

 
(2,928
)
 
100
Mortgage- and asset-backed securities
40,106

 
(66
)
 
29
 
15,031

 
(477
)
 
14
Total fixed-maturity securities
77,386

 
(539
)
 

 
115,440

 
(4,649
)
 

Equity securities
1,539

 
(10
)
 
5
 
2,739

 
(390
)
 
2
Total fixed-maturity and equity securities
$
78,925

 
$
(549
)
 

 
$
118,179

 
$
(5,039
)
 

 
December 31, 2013
 
Less than 12 months
 
12 months or longer
 
Fair value
 
Unrealized
losses
 
Number
of
securities
 
Fair value
 
Unrealized
losses
 
Number
of
securities
 
(Dollars in thousands)
Fixed-maturity securities:
 
 
 
 
 
 
 
 
 
 
 
U.S. government and agencies
$
3,817

 
$
(36
)
 
3
 
$
859

 
$
(91
)
 
2
Foreign government
34,869

 
(2,190
)
 
47
 
5,999

 
(576
)
 
13
States and political subdivisions
8,520

 
(468
)
 
11
 
152

 

(1) 
1
Corporates
296,192

 
(9,510
)
 
295
 
19,022

 
(2,421
)
 
31
Mortgage- and asset-backed securities
54,215

 
(536
)
 
46
 
10,523

 
(494
)
 
9
Total fixed-maturity securities
397,613

 
(12,740
)
 

 
36,555

 
(3,582
)
 

Equity securities
3,081

 
(633
)
 
7
 

 

 
Total fixed-maturity and equity securities
$
400,694

 
$
(13,373
)
 

 
$
36,555

 
$
(3,582
)
 

____________________
(1) 
Less than one thousand.
The amortized cost and fair value of available-for-sale fixed-maturity securities in default were as follows:
 
June 30, 2014
 
December 31, 2013
 
Amortized cost
 
Fair value
 
Amortized cost
 
Fair value
 
(In thousands)
Fixed-maturity securities in default
$
31

 
$
292

 
$
31

 
$
267



12


Impairment charges recognized in earnings on available-for-sale securities were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Impairments on fixed-maturity securities not in default
$
221

 
$
1

 
$
370

 
$
72

The securities noted above were considered to be other-than-temporarily impaired due to adverse credit events, such as news of an impending filing for bankruptcy; analyses of the issuer’s most recent financial statements or other information in which liquidity deficiencies, significant losses and large declines in capitalization were evident; or analyses of rating agency information for issuances with severe ratings downgrades that indicated a significant increase in the possibility of default.
As of June 30, 2014, the unrealized losses on our invested asset portfolio were largely caused by interest rate sensitivity and, to a lesser extent, changes in credit spreads. We believe that fluctuations caused by interest rate movement have little bearing on the recoverability of our investments. Because we have the ability to hold these investments until a market price recovery or maturity and we have no present intention to dispose of them, we do not consider these investments to be other-than-temporarily impaired.
Net impairment losses recognized in earnings were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Impairment losses related to securities which the Company does not intend to sell or more-likely-than-not will not be required to sell:
 
 
 
 
 
 
 
Total OTTI losses recognized
$

 
$
5

 
$

 
$
20

Less portion of OTTI loss recognized in accumulated other comprehensive income (loss)

 
(4
)
 

 
(19
)
Net impairment losses recognized in earnings for securities which the Company does not intend to sell or more-likely-than-not will not be required to sell before recovery

 
1

 

 
1

OTTI losses recognized in earnings for securities which the Company intends to sell or more-likely-than-not will be required to sell before recovery
221

 

 
370

 
71

Net impairment losses recognized in earnings
$
221

 
$
1

 
$
370

 
$
72

The rollforward of the credit-related losses recognized in income for all fixed-maturity securities still held follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Cumulative OTTI credit losses recognized for securities still held, beginning of period
$
14,665

 
$
14,242

 
$
14,516

 
$
14,171

Additions for OTTI securities where no credit losses were recognized prior to the beginning of the period
192

 

 
341

 
71

Additions for OTTI securities where credit losses have been recognized prior to the beginning of the period
29

 
1

 
29

 
1

Reductions due to sales, maturities or calls of credit impaired securities
(538
)
 

 
(538
)
 

Cumulative OTTI credit losses recognized for securities still held, end of period
$
14,348

 
$
14,243

 
$
14,348

 
$
14,243



13


Derivatives. Embedded conversion options associated with fixed-maturity securities are bifurcated from the fixed-maturity security host contracts and separately recognized as equity securities. The change in fair value of these bifurcated conversion options is reflected in realized investment gains (losses), including OTTI losses. As of June 30, 2014 and December 31, 2013, the fair value of these bifurcated options was approximately $6.0 million and $4.6 million, respectively.
We have a deferred loss related to closed forward contracts, which were settled several years ago, that were used to mitigate our exposure to foreign currency exchange rates that resulted from the net investment in our Canadian operations. The amount of deferred loss included in accumulated other comprehensive income was approximately $26.4 million as of June 30, 2014 and December 31, 2013. While we have no current intention to do so, these deferred losses will not be recognized until such time as we sell or substantially liquidate our Canadian operations.

(5) Fair Value of Financial Instruments
Fair value is the price that would be received upon the sale of an asset in an orderly transaction between market participants at the measurement date. Fair value measurements are based upon observable and unobservable inputs. Observable inputs reflect market data obtained from independent sources, while unobservable inputs reflect our view of market assumptions in the absence of observable market information. We classify and disclose all invested assets carried at fair value in one of the following three categories:
Level 1. Quoted prices for identical instruments in active markets. Level 1 primarily consists of financial instruments whose value is based on quoted market prices in active markets, such as exchange-traded common stocks and actively traded mutual fund investments;
Level 2. Quoted prices for similar instruments in active markets; quoted prices for identical or similar instruments in markets that are not active; and model-derived valuations in which all significant inputs and significant value drivers are observable in active markets. Level 2 includes those financial instruments that are valued using industry-standard pricing methodologies, models or other valuation methodologies. Various inputs are considered in deriving the fair value of the underlying financial instrument, including interest rate, credit spread, and foreign exchange rates. All significant inputs are observable, or derived from observable information in the marketplace or are supported by observable levels at which transactions are executed in the marketplace. Financial instruments in this category primarily include: certain public and private corporate fixed-maturity and equity securities; government or agency securities; certain mortgage- and asset-backed securities and certain non-exchange-traded derivatives, such as currency swaps and forwards; and
Level 3. Valuations derived from valuation techniques in which one or more significant inputs or significant value drivers are unobservable. Level 3 consists of financial instruments whose fair value is estimated based on industry-standard pricing methodologies and models using significant inputs not based on, nor corroborated by, readily available market information. Valuations for this category primarily consist of non-binding broker quotes. Financial instruments in this category primarily include less liquid fixed-maturity corporate securities.
As of each reporting period, all assets and liabilities recorded at fair value are classified in their entirety based on the lowest level of input (Level 3 being the lowest) that is significant to the fair value measurement. Significant levels of estimation and judgment are required to determine the fair value of certain of our investments. The factors influencing these estimations and judgments are subject to change in subsequent reporting periods.


14


The estimated fair value and hierarchy classifications for assets and liabilities that are measured at fair value on a recurring basis were as follows:
 
June 30, 2014
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(In thousands)
Fair value assets:
 
 
 
 
 
 
 
Fixed-maturity securities:
 
 
 
 
 
 
 
U.S. government and agencies
$

 
$
10,237

 
$

 
$
10,237

Foreign government

 
127,944

 

 
127,944

States and political subdivisions

 
37,490

 

 
37,490

Corporates
1,551

 
1,338,338

 
238

 
1,340,127

Mortgage- and asset-backed securities

 
286,899

 
1,466

 
288,365

Total fixed-maturity securities
1,551

 
1,800,908

 
1,704

 
1,804,163

Equity securities
43,942

 
6,446

 
48

 
50,436

Trading securities

 
9,236

 

 
9,236

Separate accounts

 
2,581,659

 

 
2,581,659

Total fair value assets
$
45,493

 
$
4,398,249

 
$
1,752

 
$
4,445,494

Fair value liabilities:
 
 
 
 
 
 
 
Currency swaps
$

 
$
173

 
$

 
$
173

Separate accounts

 
2,581,659

 

 
2,581,659

Total fair value liabilities
$

 
$
2,581,832

 
$

 
$
2,581,832

 
December 31, 2013
 
Level 1
 
Level 2
 
Level 3
 
Total
 
(In thousands)
Fair value assets:
 
 
 
 
 
 
 
Fixed-maturity securities:
 
 
 
 
 
 
 
     U.S. government and agencies
$

 
$
9,054

 
$

 
$
9,054

     Foreign government

 
116,356

 

 
116,356

     States and political subdivisions

 
33,700

 

 
33,700

     Corporates
1,282

 
1,310,739

 
693

 
1,312,714

     Mortgage- and asset-backed securities

 
282,341

 
1,547

 
283,888

          Total fixed-maturity securities
1,282

 
1,752,190

 
2,240

 
1,755,712

Equity securities
34,868

 
4,978

 
48

 
39,894

Trading securities

 
12,991

 

 
12,991

Separate accounts

 
2,503,829

 

 
2,503,829

          Total fair value assets
$
36,150

 
$
4,273,988

 
$
2,288

 
$
4,312,426

Fair value liabilities:
 
 
 
 
 
 
 
Currency swaps
$

 
$
88

 
$

 
$
88

Separate accounts

 
2,503,829

 

 
2,503,829

           Total fair value liabilities
$

 
$
2,503,917

 
$

 
$
2,503,917

In assessing fair value of our investments, we use a third-party pricing service for approximately 94% of our securities. The remaining securities are primarily thinly traded securities valued using models based on observable inputs on public corporate spreads having similar tenors (e.g., sector, average life and quality rating) and liquidity and yield based on quality rating, average life and treasury yields. All observable data inputs are corroborated by independent third-party data. In the absence of sufficient observable inputs, we utilize non-binding broker quotes, which are reflected in our Level 3 classification as we are unable to evaluate the valuation technique(s) or significant inputs used to develop the quotes. Therefore, we do not internally develop the quantitative unobservable inputs used in measuring the fair value of Level 3 investments. However, we do corroborate pricing information provided by our third-party pricing servicing by performing a review of selected securities. Our review activities include obtaining detailed information about the assumptions, inputs and methodologies used in pricing the security;


15


documenting this information; and corroborating it by comparison to independently obtained prices and or independently developed pricing methodologies.
Furthermore, we perform internal reasonableness assessments on fair value determinations within our portfolio throughout the quarter and at quarter-end, including pricing variance analyses and comparisons to alternative pricing sources and benchmark returns. If a fair value appears unusual relative to these assessments, we will re-examine the inputs and may challenge a fair value assessment made by the pricing service. If there is a known pricing error, we will request a reassessment by the pricing service. If the pricing service is unable to perform the reassessment on a timely basis, we will determine the appropriate price by requesting a reassessment from an alternative pricing service or other qualified source as necessary. We do not adjust quotes or prices except in a rare circumstance to resolve a known error.
Because many fixed-maturity securities do not trade on a daily basis, fair value is determined using industry-standard methodologies by applying available market information through processes such as U.S. Treasury curves, benchmarking of similar securities, sector groupings, quotes from market participants and matrix pricing. Observable information is compiled and integrates relevant credit information, perceived market movements and sector news. Additionally, security prices are periodically back-tested to validate and/or refine models as conditions warrant. Market indicators and industry and economic events are also monitored as triggers to obtain additional data. For certain structured securities with limited trading activity, industry-standard pricing methodologies use adjusted market information, such as index prices or discounting expected future cash flows, to estimate fair value. If these measures are not deemed observable for a particular security, the security will be classified as Level 3 in the fair value hierarchy.
Where specific market information is unavailable for certain securities, pricing models produce estimates of fair value primarily using Level 2 inputs along with certain Level 3 inputs. These models include matrix pricing. The pricing matrix uses current treasury rates and credit spreads received from third-party sources to estimate fair value. The credit spreads incorporate the issuer’s industry- or issuer-specific credit characteristics and the security’s time to maturity, if warranted. Remaining unpriced securities are valued using an estimate of fair value based on indicative market prices that include significant unobservable inputs not based on, nor corroborated by, market information, including the utilization of non-binding broker quotes.
The roll-forward of the Level 3 assets measured at fair value on a recurring basis was as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Level 3 assets, beginning of period
$
2,356

 
$
4,256

 
$
2,288

 
$
5,221

Net unrealized gains (losses) included in other comprehensive income
(222
)
 
(189
)
 
(102
)
 
(166
)
Net realized gains (losses) included in realized investment gains (losses), including other-than-temporary impairment losses
327

 
69

 
327

 
130

Purchases

 
3,906

 

 
4,383

Sales

 
(5
)
 

 
(15
)
Settlements
(709
)
 
(174
)
 
(761
)
 
(699
)
Transfers into Level 3

 
986

 

 
986

Transfers out of Level 3

 
(416
)
 

 
(1,407
)
Level 3 assets, end of period
$
1,752

 
$
8,433

 
$
1,752

 
$
8,433

We obtain independent pricing quotes based on observable inputs as of the end of the reporting period for all securities in Level 2. Those inputs include benchmark yields, reported trades, broker/dealer quotes, issuer spreads, two-sided markets, benchmark securities, market bids/offers, quoted prices for similar instruments in markets that are not active, and other relevant data. We monitor these inputs for market indicators, industry and economic events. We recognize transfers into new levels and out of previous levels as of the end of the reporting period, including interim reporting periods, as applicable. There were no transfers between Level 1 and Level 2 during the three and six months ended June 30, 2014 and 2013. In addition, there were no transfers between Level 1 and Level 3 during the three and six months ended June 30, 2014 and 2013.
Invested assets included in the transfer from Level 3 to Level 2 during the three and six months ended June 30, 2013 primarily were fixed-maturity investments for which we were able to obtain independent pricing quotes based


16


on observable inputs. Invested assets included in the transfer from Level 2 to Level 3 during the three the six months ended June 30, 2013 primarily were fixed-maturity investments for which we were unable to corroborate independent broker quotes with observable market data.
The table below is a summary of the estimated fair value for financial instruments.
 
June 30, 2014
 
December 31, 2013
 
Carrying
value
 
Estimated
fair value
 
Carrying
value
 
Estimated
fair value
 
(In thousands)
Assets:
 
 
 
 
 
 
 
Fixed-maturity securities
$
1,804,163

 
$
1,804,163

 
$
1,755,712

 
$
1,755,712

Equity securities
50,436

 
50,436

 
39,894

 
39,894

Trading securities
9,236

 
9,236

 
12,991

 
12,991

Policy loans
28,378

 
28,378

 
26,806

 
26,806

Deposit asset underlying 10% coinsurance agreement
139,057

 
139,057

 
124,413

 
124,413

Separate accounts
2,581,659

 
2,581,659

 
2,503,829

 
2,503,829

Liabilities:
 
 
 
 
 
 
 
Notes payable
$
374,506

 
$
408,232

 
$
374,481

 
$
385,161

Currency swaps
173

 
173

 
88

 
88

Separate accounts
2,581,659

 
2,581,659

 
2,503,829

 
2,503,829

The fair values of financial instruments presented above are estimates of the fair values at a specific point in time using various sources and methods, including market quotations and a complex matrix system that takes into account issuer sector, quality, and spreads in the current marketplace.
Recurring fair value measurements. Estimated fair values of investments in available-for-sale fixed-maturity securities are principally a function of current spreads and interest rates that are corroborated by independent third-party data. Therefore, the fair values presented are indicative of amounts we could realize or settle at the respective balance sheet date. We do not necessarily intend to dispose of or liquidate such instruments prior to maturity. Trading securities, which primarily consist of fixed-maturity securities, are carried at fair value. Equity securities, including common and nonredeemable preferred stocks, are carried at fair value. Currency swaps are stated at fair value. Segregated funds in separate accounts are carried at the underlying value of the variable insurance contracts, which is fair value.
Nonrecurring fair value measurements. Policy loans, which are categorized as Level 3 fair value measurements, are carried at the unpaid principal balances. The fair value of policy loans approximate the unpaid principal balances as the timing of repayment is uncertain and the loans are collateralized by the amount of the policy. The deposit asset underlying the 10% coinsurance agreement with Prime Reinsurance Company, Inc. ("Prime Re"), an affiliate of Citigroup Inc. ("Citigroup"), represents the value of the assets necessary to back the economic reserves held in support of the reinsurance agreement. The carrying value of this deposit asset approximates fair value, which is categorized as Level 3 in the fair value hierarchy. Notes payable represent our publicly-traded senior notes and are valued as a Level 2 fair value measurement using the quoted market price for our notes.
The carrying amounts for cash and cash equivalents, receivables, accrued investment income, accounts payable, cash collateral and payables for security transactions approximate their fair values due to the short-term nature of these instruments. Consequently, such financial instruments are not included in the above table.

(6)
Reinsurance
We use reinsurance extensively, which has a significant effect on our results of operations. Reinsurance arrangements do not relieve us of our primary obligation to the policyholder. We monitor the concentration of credit risk we have with any reinsurer, as well as the financial condition of the reinsurers.


17


Details on in-force life insurance follow:
 
June 30,
2014
 
December 31,
2013
 
(Dollars in thousands)
Direct life insurance in force
$
686,283,758

 
$
679,337,825

Amounts ceded to other companies
(607,151,318
)
 
(601,309,340
)
Net life insurance in force
$
79,132,440

 
$
78,028,485

Percentage of reinsured life insurance in force
88
%
 
89
%
Due from reinsurers includes ceded reserve balances and ceded claim liabilities. Reinsurance receivable and financial strength ratings by reinsurer were as follows:
 
June 30, 2014
 
December 31, 2013
Reinsurance
receivable
 
A.M. Best
rating
 
Reinsurance
receivable
 
A.M. Best
rating
(In thousands)
Prime Reinsurance Company(1)
$
2,602,833

 
NR
 
$
2,572,800

 
NR
SCOR Global Life Reinsurance Companies(3)
365,548

 
A
 
372,479

 
A
Financial Reassurance Company 2010, Ltd.(1)
345,032

 
NR
 
343,144

 
NR
Swiss Re Life & Health America Inc.(2)
256,228

 
A+
 
260,775

 
A+
American Health and Life Insurance Company(1)
174,520

 
A-
 
174,722

 
A-
Munich American Reassurance Company
102,693

 
A+
 
100,856

 
A+
Korean Reinsurance Company
88,767

 
A
 
89,405

 
A
RGA Reinsurance Company
76,591

 
A+
 
75,629

 
A+
Toa Reinsurance Company
18,257

 
A+
 
18,824

 
A+
Hannover Life Reassurance Company
16,901

 
A+
 
16,862

 
A+
All other reinsurers
30,364

 
 
29,558

 
Due from reinsurers
$
4,077,734

 
 
 
$
4,055,054

 
 
____________________ 
NR – not rated
(1) 
Reinsurers are affiliates of Citigroup. Amounts shown are net of their share of the reinsurance receivable from other reinsurers.
(2) 
Includes amounts ceded to Lincoln National Life Insurance and 100% retroceded to Swiss Re Life & Health America Inc.
(3) 
Includes amounts ceded to Generali USA Life Reassurance Company due to its purchase by the parent company of SCOR Global Life Reinsurance Companies in October 2013 and amounts retroceded from Transamerica Reinsurance Companies.

(7)
Notes Payable
At June 30, 2014, the Company had $375.0 million of publicly-traded, senior unsecured notes with an annual interest rate of 4.75% that are scheduled to mature on July 15, 2022 (the "Senior Notes"). As of June 30, 2014, we were in compliance with the covenants of the Senior Notes. No events of default occurred on the Senior Notes during the six months ended June 30, 2014.
Further discussion on the Company’s notes payable is included in Note 9 (Notes Payable) to our consolidated financial statements within our 2013 Annual Report.



18


(8)
Stockholders’ Equity
A reconciliation of the number of shares of our common stock follows.
 
Six months ended June 30,
 
2014
 
2013
 
(In thousands)
Common stock, beginning of period
54,834

 
56,374

Shares of restricted common stock issued

 
289

Shares issued for stock options exercised
4

 

Shares of common stock issued upon lapse of restricted stock units ("RSUs")
269

 
783

Common stock retired
(913
)
 
(2,942
)
Common stock, end of period
54,194

 
54,504

The above reconciliation excludes RSUs, which do not have voting rights. As the RSUs lapse, we issue common shares with voting rights. As of June 30, 2014, we had a total of approximately 1.2 million RSUs outstanding.
Our Board of Directors authorized a share repurchase program for up to $150.0 million of our outstanding common stock (the "share repurchase program"). Under the share repurchase program, we repurchased 763,902 shares of our common stock in open market transactions for an aggregate purchase price of approximately $35.0 million during the first six months of 2014. As of June 30, 2014, there is approximately $115.0 million remaining for repurchases of our outstanding common stock under the share repurchase program.

(9)
Earnings Per Share
The Company has outstanding common stock and equity awards that consist of restricted stock, RSUs and stock options. In addition, warrants to purchase additional shares of our common stock were outstanding until we repurchased and retired these warrants in 2013. The restricted stock and outstanding RSUs maintain non-forfeitable dividend rights that result in dividend payment obligations on a one-to-one ratio with common shares for any future dividend declarations. Unvested restricted stock and unvested RSUs are deemed participating securities for purposes of calculating earnings per share ("EPS") as they maintain dividend rights.
As a result of issuing restricted stock and outstanding RSUs that are deemed participating securities, we calculate EPS using the two-class method. Under the two-class method, we allocate earnings to common shares (excluding unvested restricted stock) and vested RSUs outstanding for the period. Earnings attributable to unvested participating securities, along with the corresponding share counts, are excluded from EPS as reflected in our unaudited condensed consolidated statements of income.
In calculating basic EPS, we deduct any dividends and undistributed earnings allocated to unvested restricted stock and unvested RSUs from net income and then divide the result by the weighted-average number of common shares, fully vested restricted stock, and fully vested RSUs outstanding for the period.
We determine the potential dilutive effect of warrants and stock options outstanding on EPS using the treasury-stock method. Under this method, we determine the proceeds that would be received from the exercise of the warrants and stock options outstanding, which includes cash received for the exercise price, the remaining unrecognized stock option compensation expense and the resulting effect on the income tax deduction from the exercise of stock options. We then use the average market price of our common shares during the period the warrants and stock options were outstanding to determine how many shares we could repurchase with the proceeds raised from the exercise of the warrants and stock options outstanding. The net incremental share count issued represents the potential dilutive securities. We then reallocate earnings to common shares, fully vested restricted stock, and fully vested RSUs outstanding by incorporating the increased fully diluted share count to determine diluted EPS.


19


The calculation of basic and diluted EPS follows.
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands, except per-share amounts)
Basic EPS
 
 
 
 
 
 
 
Numerator (continuing operations):
 
 
 
 
 
 
 
Income from continuing operations
$
49,271

 
$
43,168

 
$
92,757

 
$
81,303

Income attributable to unvested participating securities
(542
)
 
(548
)
 
(1,102
)
 
(1,582
)
Income from continuing operations used in calculating basic EPS
$
48,729

 
$
42,620

 
$
91,655

 
$
79,721

Numerator (discontinued operations):
 
 
 
 
 
 
 
Income from discontinued operations
$

 
$
322

 
$
1,595

 
$
1,032

Income attributable to unvested participating securities

 
(4
)
 
(20
)
 
(20
)
Income from discontinued operations used in calculating basic EPS
$

 
$
318

 
$
1,575

 
$
1,012

Denominator:
 
 
 
 
 
 
 
Weighted-average vested shares
54,927

 
56,511

 
55,075

 
56,553

Basic EPS from continuing operations
$
0.89

 
$
0.75

 
$
1.66

 
$
1.41

Basic EPS from discontinued operations
$

 
$
0.01

 
$
0.03

 
$
0.02

 
 
 
 
 
 
 
 
Diluted EPS
 
 
 
 
 
 
 
Numerator (continuing operations):
 
 
 
 
 
 
 
Income from continuing operations
$
49,271

 
$
43,168

 
$
92,757

 
$
81,303

Income attributable to unvested participating securities
(542
)
 
(538
)
 
(1,102
)
 
(1,546
)
Income from continuing operations used in calculating diluted EPS
$
48,729

 
$
42,630

 
$
91,655

 
$
79,757

Numerator (discontinued operations):
 
 
 
 
 
 
 
Income from discontinued operations
$

 
$
322

 
$
1,595

 
$
1,032

Income attributable to unvested participating securities

 
(4
)
 
(20
)
 
(20
)
Income from discontinued operations used in calculating diluted EPS
$

 
$
318

 
$
1,575

 
$
1,012

Denominator:
 
 
 
 
 
 
 
Weighted-average vested shares
54,927

 
56,511

 
55,075

 
56,553

Dilutive effect of incremental shares if issued for warrants outstanding

 
1,338

 

 
1,574

Dilutive effect of incremental shares to be issued for equity awards
23

 

 
22

 

Weighted-average shares used in calculating diluted EPS
54,950

 
57,849

 
55,097

 
58,127

Diluted EPS from continuing operations
$
0.89

 
$
0.73

 
$
1.66

 
$
1.37

Diluted EPS from discontinued operations
$

 
$
0.01

 
$
0.03

 
$
0.02


(10)
Share-Based Transactions
The Company has outstanding equity awards under its Omnibus Incentive Plan ("OIP"). The OIP provides for the issuance of equity awards, including stock options, stock appreciation rights, restricted stock, deferred stock, RSUs, unrestricted stock, as well as cash-based awards. In addition to time-based vesting requirements, awards granted under the OIP also may be subject to specified performance criteria. Since 2010, the Company has issued equity awards to our management (officers and other key employees), non-employee directors, and sales force leaders under the OIP. For more information on equity awards granted under the OIP, see Note 13 (Share-Based Compensation) to our consolidated financial statements within our 2013 Annual Report.


20


In connection with our granting of equity awards to our management and members of the Board of Directors, we recognize expense over the service period of the equity award. Additionally, to the extent that equity awards to members of our sales force are an incremental direct cost of successful acquisitions or renewals of life insurance policies that result directly from and are essential to the policy acquisition(s) and would not have been incurred had the policy acquisition(s) not occurred, we defer and amortize the fair value of these awards in the same manner as other deferred policy acquisition costs.
The impacts of equity awards granted are as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
 
(In thousands)
Total equity awards expense recognized
$
2,988

 
$
2,755

 
$
5,836

 
$
7,952

Quarterly incentive awards expense deferred
3,543

 
4,335

 
7,330

 
8,141


(11) Commitments and Contingent Liabilities
Letter of Credit
Peach Re maintains a credit facility agreement with Deutsche Bank (the "Credit Facility Agreement") to support certain obligations for a portion of the statutory accounting-based reserves (commonly referred to as Regulation XXX reserves) related to the Peach Re Coinsurance Agreement. Under the Credit Facility Agreement, Deutsche Bank issued a letter of credit for the benefit of Primerica Life. As of June 30, 2014, the Company was in compliance with all financial covenants under the Credit Facility Agreement.
Further discussion on the Company’s letter of credit is included in Note 15 (Commitments and Contingent Liabilities) to our consolidated financial statements within our 2013 Annual Report.
Contingent Liabilities
The Company is involved from time to time in legal disputes, regulatory inquiries and arbitration proceedings in the normal course of business. These disputes are subject to uncertainties, including the large and/or indeterminate amounts sought in certain of these matters and the inherent unpredictability of litigation. As such, the Company is unable to estimate the possible loss or range of loss that may result from these matters.
Beginning in late 2011, numerous FINRA ("Financial Industry Regulatory Association") arbitration claims were filed, along with lawsuits in Florida state courts, against our subsidiary, PFS Investments, and certain of its registered representatives seeking damages arising from the allegation that the representatives improperly recommended that the claimants transfer their retirement benefits from the Florida Retirement System's defined benefit plan to its defined contribution plan.
In January 2014, PFS Investments entered into a memorandum of understanding to resolve this pending litigation. As of December 31, 2013, we had established a contingent liability for $9.3 million for the fair value of estimated benefits to be paid to the settling claimants through deferred payments that would begin in 2024 (the "deferred annuity settlement") and approximately $6.4 million for estimated related costs, including awards relating to prior arbitrations, other potential settlements, and the payment of claimants’ attorneys' fees and expenses. The memorandum of understanding required that a certain percentage of claimants agree to the settlement. By April 2014, a required percentage of claimants had signed settlement agreements and releases. In June 2014, in accordance with the memorandum of understanding and claimant settlement agreements and releases, we reached an agreement with an independent third party to assume the liability for the deferred annuity settlement and paid cash consideration approximately equal to the contingent liability that had been recorded to fund the benefits. With this agreement, the Company is no longer obligated to manage or make payments related to the deferred annuity settlement and has not guaranteed the liability assumed by the third party. As of June 30, 2014, the Company has paid approximately $9.2 million of the estimated $9.3 million of benefits for the settling claimants and $5.8 million of the estimated $6.4 million for related costs.
The Company is currently undergoing targeted multi-state treasurer audits by 30 jurisdictions with respect to unclaimed property laws, and Primerica Life and NBLIC are engaged in a targeted multi-state market conduct examination by six jurisdictions with respect to their claims-paying practices. The Treasurer of the State of West Virginia brought a suit against Primerica Life and other insurance companies alleging violations of the West Virginia


21


unclaimed property act. The suit was dismissed, and the Treasurer has appealed. Other jurisdictions may pursue similar audits, examinations and litigation. The audits, examinations and litigation are expected to take significant time to complete, and it is unclear whether the Company will be required to compare the Death Master File to its records for periods prior to 2011, including with respect to policies which have lapsed, to determine whether benefits are owed in instances where an insured appears to have died but no claim for death benefits has been made. The potential outcome of such actions is difficult to predict but could subject the Company to adverse consequences, including, but not limited to, settlement payments, additional payments to beneficiaries and additional escheatment of funds deemed abandoned under state laws. At this time, the Company cannot reasonably estimate the likelihood or the impact of additional costs or liabilities that could result from the resolution of these matters. These actions may also result in changes to the Company's procedures for the identification and escheatment of abandoned property and other financial liability.

(12) Subsequent Events
On July 31, 2014, Vidalia Re, a newly formed special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life, and Primerica Life entered into the Vidalia Re Coinsurance Agreement. Under this agreement, Primerica Life ceded to Vidalia Re level premium term life insurance policies primarily written in 2011 and 2012, and policies written in 2013 by Primerica Life will be ceded to Vidalia Re effective June 30, 2015. The Vidalia Re Coinsurance Agreement also provides Primerica Life and Vidalia Re the option to reinsure certain policies written in 2014 and 2015 subject to specified terms and conditions.
Concurrent with the execution of the Vidalia Re Coinsurance Agreement, Vidalia Re entered into a Surplus Note Purchase Agreement (the "Surplus Note Purchase Agreement") with Hannover Life Reassurance Company of America (Bermuda) Ltd. ("Hannover Bermuda"), Hannover Life Reassurance Company of America ("Hannover Re"), and a newly formed limited liability company owned by a third party service provider (the "LLC"). Under the Surplus Note Purchase Agreement, Vidalia Re issued a surplus note with an initial principal amount of approximately $170.4 million ("Surplus Note") to the LLC in exchange for a credit enhanced note from the LLC with an equal initial principal amount ("LLC Note"). Both notes have a maturity date of December 31, 2029 and bear interest at an annual rate of 4.5%. The LLC Note, which is rated A+ by Fitch Ratings, was issued to support certain obligations of Vidalia Re for a portion of the Regulation XXX reserves related to the Vidalia Re Coinsurance Agreement. The principal amount of each note will fluctuate over time to coincide with the amount of reserves being supported. Based on the estimated reserves for ceded policies issued in 2011, 2012, and 2013, the maximum principal amounts of the LLC Note and the Surplus Note are expected to be approximately $680.0 million each. The LLC Note is guaranteed by Hannover Re through the credit enhancement feature in exchange for a fee. The financing arrangement is non-recourse to the Parent Company and Primerica Life, meaning that neither of these companies have guaranteed the Surplus Note or are otherwise liable for reimbursement for any payments required by the credit enhancement feature. The Parent Company has agreed to support Vidalia Re's obligation to pay the credit enhancement fee incurred on the LLC Note.
The LLC is a variable interest entity as its owner does not have an equity investment at risk that is sufficient to permit the LLC to finance its activities without Vidalia Re or Hannover Re. The Parent Company, Primerica Life, and Vidalia Re do not have the obligation to absorb losses related to the primary risks or sources of variability to the LLC and thus are not its primary beneficiary. Accordingly, the Company will not consolidate the LLC and will record the LLC Note as an invested asset and the equivalent Surplus Note as a debt obligation in its consolidated financial statements.

ITEM 2. MANAGEMENT'S DISCUSSION AND ANALYSIS OF FINANCIAL CONDITION AND RESULTS OF OPERATIONS.

Management’s Discussion and Analysis of Financial Condition and Results of Operations (“MD&A”) is intended to inform the reader about matters affecting the financial condition and results of operations of Primerica, Inc. (the “Parent Company”) and its subsidiaries (collectively, "we", "us" or the “Company”) for the period from December 31, 2013 to June 30, 2014. As a result, the following discussion should be read in conjunction with MD&A and the consolidated financial statements and notes thereto that are included in our Annual Report on Form 10-K for the year ended December 31, 2013 ("2013 Annual Report"). This discussion contains forward-looking statements that constitute our plans, estimates and beliefs. These forward-looking statements involve numerous risks and


22


uncertainties, including, but not limited to, those discussed under the heading “Risk Factors” in the 2013 Annual Report. Actual results may differ materially from those contained in any forward-looking statements.
This MD&A is divided into the following sections:
Business Overview
Critical Accounting Estimates
Factors Affecting Our Results
Results of Operations
Financial Condition
Liquidity and Capital Resources

Business Overview
We are a leading distributor of financial products to middle income households in the United States and Canada. We assist our clients in meeting their needs for term life insurance, which we underwrite, and mutual funds, annuities and other financial products, which we distribute primarily on behalf of third parties. We have two primary operating segments, Term Life Insurance and Investment and Savings Products, and a third segment, Corporate and Other Distributed Products.
Term Life Insurance. We distribute the term life insurance products that we originate through our three issuing life insurance company subsidiaries: Primerica Life Insurance Company (“Primerica Life”); National Benefit Life Insurance Company (“NBLIC”); and Primerica Life Insurance Company of Canada (“Primerica Life Canada”). Our in force term insurance policies have level premiums for the stated term period. As such, the policyholder pays the same amount each year. Initial policy term periods are between 10 and 35 years. While premiums are guaranteed to remain level during the initial term period (up to a maximum of 20 years in the United States), our claim obligations generally increase as our policyholders age. In addition, we incur significant upfront costs in acquiring new insurance business. Our deferral and amortization of policy acquisition costs and reserving methodology are designed to match the recognition of premium revenues with the timing of policy lapses and the payment of expected claims obligations.
Our Term Life Insurance segment results are primarily driven by sales and policies in force, accuracy of our pricing assumptions, terms and use of reinsurance, investment income, and expenses.
Investment and Savings Products. In the United States, we distribute mutual fund and managed accounts products and variable and fixed annuity products of several third-party companies. In Canada, we offer our own Primerica-branded mutual funds, as well as mutual funds of other companies, and segregated funds, which are underwritten by Primerica Life Canada.
Results in our Investment and Savings Products segment are driven by sales of mutual funds and annuities, the value of assets in client accounts for which we earn ongoing service, distribution and advisory fees and the number of fee generating accounts for which we provide administration functions or retirement plan custodial services. While our investment and savings products all have similar long-term earnings characteristics, our results in a given fiscal period are affected by changes in the overall mix of products within these broad categories.
Corporate and Other Distributed Products. Our Corporate and Other Distributed Products segment consists primarily of revenues and expenses related to other distributed products, including various insurance products underwritten by NBLIC, automobile and homeowners' insurance referrals, prepaid legal services, as well as credit information and debt referral services. These products, except for various insurance products underwritten by NBLIC, are distributed pursuant to distribution arrangements with third parties through our independent agent sales force. In addition, our Corporate and Other Distributed Products segment includes corporate income (including net investment income) and expenses not allocated to other segments, interest expense on our notes payable and realized gains and losses on our invested asset portfolio.

Critical Accounting Estimates
We prepare our financial statements in accordance with accounting principles generally accepted in the United States of America (“U.S. GAAP”). These principles are established primarily by the Financial Accounting Standards


23


Board ("FASB"). The preparation of financial statements in conformity with U.S. GAAP requires us to make estimates and assumptions based on currently available information when recording transactions resulting from business operations. Our significant accounting policies are described in Note 1 (Description of Business, Basis of Presentation, and Summary of Significant Accounting Policies) to our consolidated financial statements included in our 2013 Annual Report. The most significant items on the balance sheet are based on fair value determinations, accounting estimates and actuarial determinations, which are susceptible to changes in future periods and could affect our results of operations and financial position.
The estimates that we deem to be most critical to an understanding of our results of operations and financial position are those related to deferred policy acquisition costs ("DAC"), future policy benefit reserves and corresponding amounts due from reinsurers, income taxes, the valuation of investments, and litigation. The preparation and evaluation of these critical accounting estimates involve the use of various assumptions developed from management’s analyses and judgments. Subsequent experience or use of other assumptions could produce significantly different results.
Accounting Policy Change. During the six months ended June 30, 2014, there have been no changes in the accounting methodology for items that we have identified as critical accounting estimates. For additional information regarding critical accounting estimates, see the Critical Accounting Estimates section of MD&A included in our 2013 Annual Report.

Factors Affecting Our Results
Economic Environment. The relative strength and stability of financial markets and economies in the United States and Canada affect our growth and profitability. Our business is, and we expect will continue to be, influenced by a number of industry-wide and product-specific trends and conditions.
Economic conditions, including unemployment levels and consumer confidence, influence investment and spending decisions by middle income consumers, who are generally our primary clients. These conditions and factors also impact prospective recruits’ perceptions of the business opportunity that becoming a Primerica sales representative offers, which can drive or dampen recruiting. Consumer spending and borrowing levels affect how consumers evaluate their savings and debt management plans. In addition, interest rates and equity market returns impact consumer demand for the savings and investment products we distribute. The effects of these trends and conditions are discussed in the Results of Operations section below.
Independent Sales Force. Our ability to increase the size of our sales force is largely based on the success of our recruiting efforts and our ability to train and motivate recruits to get licensed to sell life insurance. We believe that recruitment and licensing levels are important to sales force trends and growth in recruiting and licensing is usually indicative of future growth in the overall size of the sales force. Recruiting results do not always result in commensurate changes in the size of our licensed sales force because new recruits may obtain the requisite licenses at rates above or below historical levels.
Regulatory changes can also impact the size of our independent sales force. The insurance regulators in the Canadian provinces and territories entered into a Memorandum of Understanding and related agreements to implement a new life insurance licensing examination program across Canada in early 2016. If this new licensing program is implemented under the terms set forth in the agreements, we believe it would significantly decrease the ability of applicants to obtain their life insurance licenses in Canada. At this time, we cannot quantify the impact of the new licensing program on us. However, we believe the program could result in a significant decline in the number of our new life-licensed representatives in Canada and ultimately the size of our life-licensed sales force. This could lower new life insurance sales and, over time, lower the size of our in-force life insurance premium and materially adversely affect our Canadian Term Life insurance business. See "Part II — Other Information — Item 1. Legal Proceedings." for more information.
Details on new recruits and life-licensed sales representative activity were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
New recruits
50,024

 
50,358

 
98,330

 
96,706

New life-licensed sales representatives
9,082

 
8,875

 
16,529

 
16,040



24


New recruits and new life-licensed representatives remained relatively flat in the second quarter of 2014 and grew modestly in the first half of 2014 compared to the prior year periods.
The size of our life-licensed insurance sales force was as follows:
 
June 30, 2014
 
March 31, 2014
 
December 31, 2013
Life-licensed insurance sales representatives
96,596

 
95,382

 
95,566

The life-licensed sales force at June 30, 2014 increased compared with the seasonally lower first quarter of 2014, as well as partly due to the positive effect of licensing initiatives taken in previous periods.
Term Life Insurance Segment. Our Term Life Insurance segment results are primarily driven by sales volumes, the accuracy of our pricing assumptions, terms and use of reinsurance, investment income and expenses.
Sales and policies in force. Sales of new term policies and the size and characteristics of our in force book of policies are vital to our results over the long term. Premium revenue is recognized as it is earned over the term of the policy and eligible acquisition expenses are deferred and amortized ratably with the level premiums of the underlying policies. However, because we incur significant cash outflows at or about the time policies are issued, including the payment of sales commissions and underwriting costs, changes in life insurance sales volume will have a more immediate effect on our cash flows.
Historically, we have found that, while sales volume of term life insurance products between fiscal periods may vary based on a variety of factors, the productivity of our sales representatives generally remains within a relatively narrow range (between 0.18x and 0.22x), and, consequently, our sales volume over the longer term generally correlates to the size of our sales force.
The average number of life-licensed sales representatives and the number of term life insurance policies issued, as well as the average monthly rate of new policies issued per life-licensed sales representative, were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
2013
 
2014
 
2013
Average number of life-licensed sales representatives
96,095

 
91,849

 
95,743

 
91,655

Number of new policies issued
59,569

 
57,622

 
108,889

 
107,978

Average monthly rate of new policies issued per life-licensed sales representative
0.21x

 
0.21x

 
0.19x

 
0.20x

The average monthly rate of new policies issued per life-licensed sales representative for the three months ended June 30, 2014 was consistent with historical experience. For the six months ended June 30, 2014, the average monthly rate of new policies issued per life-licensed sales representative declined slightly compared to the prior year period in part due to the impact of adverse weather conditions across North America in early 2014.
Pricing assumptions. Our pricing methodology is intended to provide us with appropriate profit margins for the risks we assume. We determine pricing classifications based on the coverage sought, such as the size and term of the policy, and certain policyholder attributes, such as age and health. In addition, we generally utilize unisex rates for our term life insurance policies. The pricing assumptions that underlie our rates are based upon our best estimates of mortality, persistency and investment yields at the time of issuance, sales force commission rates, issue and underwriting expenses, operating expenses and the characteristics of the insureds, including sex, age, underwriting class, product and amount of coverage. Our results will be affected to the extent there is a variance between our pricing assumptions and actual experience.
Persistency. Persistency is a measure of how long our insurance policies stay in force. As a general matter, persistency that is lower than our pricing assumptions adversely affects our results over the long term because we lose the recurring revenue stream associated with the policies that lapse. Determining the near-term effects of changes in persistency is more complicated. When persistency is lower than our pricing assumptions, we must accelerate the amortization of DAC. The resultant increase in amortization expense is offset by a corresponding release of reserves associated with lapsed policies, which causes a reduction in benefits and claims expense. The future policy benefit reserves associated with any given policy will change over the term of such policy. As a general matter, future policy benefit reserves are lowest at the inception of a policy term and rise steadily to a peak before declining to zero at the expiration of the policy term. Accordingly, depending on when the lapse occurs in relation to the overall policy term, the reduction in benefits and claims expense may be greater or less than the increase in amortization expense,


25


and, consequently, the effects on earnings for a given period could be positive or negative. Persistency levels will impact results to the extent actual experience deviates from the persistency assumptions used to price our products.
Mortality. Our profitability will fluctuate to the extent actual mortality rates differ from those used in our pricing assumptions. We mitigate a significant portion of our mortality exposure through reinsurance.
Investment Yields. We use investment yield rates based on yields available at the time a policy is issued. For policies issued in 2010 and after, we have been using an increasing interest rate assumption to reflect the historically low interest rate environment. Both DAC and the future policy benefit reserve liability increase with the assumed investment yield rate. Since DAC is higher than the future policy benefit reserve liability in the early years of a policy, a lower assumed investment yield generally will result in lower profits. In the later years, when the future policy benefit reserve liability is higher than DAC, a lower assumed investment yield generally will result in higher profits. These assumed investment yields, which like other pricing assumptions are locked in at issue, impact the timing but not the aggregate amount of DAC and future policy benefit reserve changes. Actual investment yields will impact net investment income allocated to the Term Life Insurance segment, but will not impact DAC or the reserve liability.
Reinsurance. We use reinsurance extensively, which has a significant effect on our results of operations. Since the mid-1990s, we have reinsured between 60% and 90% of the mortality risk on our U.S. term life insurance policies on a quota share yearly renewable term ("YRT") basis. In Canada, we previously utilized reinsurance arrangements similar to the U.S. in certain years and reinsured only face amounts above $500,000 in other years. However, in the first quarter of 2012, we entered into a YRT reinsurance arrangement in Canada similar to our U.S. program that reinsures 80% of the face amount for every policy sold. YRT reinsurance permits us to set future mortality at contractual rates by policy class. To the extent actual mortality experience is more or less favorable than the contractual rate, the reinsurer will earn incremental profits or bear the incremental cost, as applicable. In contrast to coinsurance, which is intended to eliminate all risks (other than counterparty risk of the reinsurer) and rewards associated with a specified percentage of the block of policies subject to the reinsurance arrangement, the YRT reinsurance arrangements we enter into are intended only to reduce volatility associated with variances between estimated and actual mortality rates.
In 2010, as part of our corporate reorganization, we entered into significant coinsurance transactions (the "coinsurance transactions") with three affiliates (collectively, the "Citigroup reinsurers") of Citigroup Inc. ("Citigroup") and ceded between 80% and 90% of the risks and rewards of our term life insurance policies that were in force at year-end 2009. We continue to administer all policies subject to these coinsurance agreements. With each successive period, we expect revenue and earnings growth to continue to decelerate as the size of our in-force book grows and incremental sales have a reduced marginal effect on the size of the then-existing in force book.
The effect of our reinsurance arrangements on ceded premiums and benefits and expenses on our statement of income follows:
Ceded premiums. Ceded premiums are the premiums we pay to reinsurers. These amounts are deducted from the direct premiums we earn to calculate our net premium revenues. Similar to direct premium revenues, ceded coinsurance premiums remain level over the initial term of the insurance policy. Ceded YRT premiums increase over the period that the policy has been in force. Accordingly, ceded YRT premiums generally constitute an increasing percentage of direct premiums over the policy term.
Benefits and claims. Benefits and claims include incurred claim amounts and changes in future policy benefit reserves. Reinsurance reduces incurred claims in direct proportion to the percentage ceded. Coinsurance also reduces the change in future policy benefit reserves in direct proportion to the percentage ceded, while YRT reinsurance does not significantly impact the change in these reserves.
Amortization of DAC. DAC, and therefore amortization of DAC, is reduced on a pro-rata basis for the coinsured business, including the business reinsured with Citigroup. There is no impact on amortization of DAC associated with our YRT contracts.
Insurance expenses. Insurance expenses are reduced by the allowances received from coinsurance, including the business reinsured with Citigroup. There is no impact on insurance expenses associated with our YRT contracts.
We may alter our reinsurance practices at any time due to the unavailability of YRT reinsurance at attractive rates or the availability of alternatives to reduce our risk exposure. We presently intend to continue ceding approximately 90% of our U.S. mortality risk on new business and approximately 80% of our Canadian mortality risk on new business.


26


Net investment income. Net investment income is allocated to the Term Life Insurance segment based on the book value of the invested assets necessary to meet statutory reserve requirements and our targeted capital objectives. Net investment income is impacted by the performance of our invested asset portfolio, which can be affected by interest rates, credit spreads and the mix of invested assets.
Expenses. Results are also affected by variances in client acquisition, maintenance and administration expense levels.
Investment and Savings Products Segment. Our Investment and Savings Products segment results are primarily driven by sales, the value of assets in client accounts for which we earn ongoing management, service and distribution fees and the number of fee generating accounts we administer.
Sales. We earn commissions and fees, such as dealer re-allowances, and marketing and support fees, based on sales of mutual fund products and annuities. Sales of investment and savings products are influenced by the overall demand for investment products in the United States and Canada, as well as by the size and productivity of our sales force. We generally experience seasonality in our Investment and Savings Products segment results due to our high concentration of sales of retirement account products. These accounts are typically funded in February through April, coincident with our clients' tax return preparation season. While we believe the size of our sales force is a factor in driving sales volume in this segment, there are a number of other variables, such as economic and market conditions, which may have a significantly greater effect on sales volume in any given fiscal period.
Asset values in client accounts. We earn marketing and distribution fees (trail commissions or, with respect to U.S. mutual funds, 12b-1 fees) on mutual fund and annuity assets in the United States and Canada. In the United States, we also earn investment advisory fees on assets in the managed accounts program. In Canada, we earn management fees on certain mutual fund assets and on the segregated funds for which we serve as investment manager. Asset values are influenced by new product sales, ongoing contributions to existing accounts, redemptions and the change in market values in existing accounts. While we offer a wide variety of asset classes and investment styles, our clients' accounts are primarily invested in equity funds.
Accounts. We earn recordkeeping fees for administrative functions we perform on behalf of several of our retail and managed mutual fund providers and custodial fees for services as a non-bank custodian for certain of our clients’ retirement plan accounts.
Sales mix. While our investment and savings products all have similar long-term earnings characteristics, our results in a given fiscal period will be affected by changes in the overall mix of products within these categories. Examples of changes in the sales mix that influence our results include the following:
sales of annuity products in the United States will generate higher revenues in the period such sales occur than sales of other investment products that either generate lower upfront revenues or, in the case of managed accounts and segregated funds, no upfront revenues;
sales of a higher proportion of managed accounts and segregated funds products will generally extend the time over which revenues can be earned because we are entitled to higher revenues based on assets under management for these accounts in lieu of upfront revenues; and
sales of a higher proportion of mutual fund products and the composition of the fund families sold will impact the timing and amount of revenue we earn given the marketing, support, recordkeeping and custodial services we perform for the various mutual fund products we distribute.
Corporate and Other Distributed Products Segment. We earn revenues and pay commissions and referral fees for various other insurance products, prepaid legal services and other financial products, all of which are originated by third parties. NBLIC also has in-force policies from several discontinued lines of insurance. During the first quarter of 2014, NBLIC sold its short-term statutory disability benefit insurance business ("DBL") to AmTrust North America, Inc., and the operating results have been reported as discontinued operations for all periods presented. During the second quarter of 2014, NBLIC ceased the marketing and underwriting of new student life insurance policies but will continue to administer the existing block of student life business. Corporate and Other Distributed Products segment net investment income is composed of two elements: the remainder of net investment income not allocated to our Term Life Insurance segment and the market return associated with the deposit asset underlying a 10% coinsurance agreement with the Citigroup reinsurers ("10% Coinsurance Agreement").
The Corporate and Other Distributed Products segment is affected by corporate income and expenses not allocated to our other segments, net investment income (other than net investment income allocated to our Term Life Insurance segment), general and administrative expenses (other than expenses that are allocated to our Term Life Insurance or Investment and Savings Products segments), equity awards granted to management and our sales


27


force leaders at the time of our April 2010 initial public offering ("IPO"), interest expense on notes payable and realized gains and losses on our invested asset portfolio.
Capital Structure. Our financial results have also been affected by changes in our capital structure, including the issuance of our senior unsecured notes and redundant reserve financings, as well as repurchases of shares and warrants of our common stock. For additional information regarding factors affecting our results, see Factors Affecting Our Results in our 2013 Annual Report.

Results of Operations
Primerica, Inc. and Subsidiaries Results. Our results of operations were as follows:
 
Three months ended June 30,
 
Change
 
Six months ended June 30,
 
Change
 
2014
 
2013
 
$
 
%
 
2014
 
2013
 
$
 
%
 
(Dollars in thousands)
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct premiums
$
576,740

 
$
568,391

 
$
8,349

 
1
 %
 
$
1,144,945

 
$
1,129,295

 
$
15,650

 
1
 %
Ceded premiums
(410,546
)
 
(417,450
)
 
(6,904
)
 
(2
)%
 
(813,261
)
 
(828,054
)
 
(14,793
)
 
(2
)%
Net premiums
166,194

 
150,941

 
15,253

 
10
 %
 
331,684

 
301,241

 
30,443

 
10
 %
Commissions and fees
132,039

 
117,182

 
14,857

 
13
 %
 
258,970

 
229,455

 
29,515

 
13
 %
Net investment income
21,681

 
21,027

 
654

 
3
 %
 
43,280

 
44,243

 
(963
)
 
(2
)%
Realized investment gains (losses), including other-than-temporary impairment losses
831

 
3,468

 
(2,637
)
 
(76
)%
 
1,094

 
5,754

 
(4,660
)
 
(81
)%
Other, net
10,385

 
10,872

 
(487
)
 
(4
)%
 
20,430

 
21,247

 
(817
)
 
(4
)%
Total revenues
331,130

 
303,490

 
27,640

 
9
 %
 
655,458

 
601,940

 
53,518

 
9
 %
Benefits and expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Benefits and claims
72,412

 
64,322

 
8,090

 
13
 %
 
147,604

 
133,138

 
14,466

 
11
 %
Amortization of DAC
32,696

 
30,112

 
2,584

 
9
 %
 
67,890

 
61,364

 
6,526

 
11
 %
Sales commissions
67,364

 
57,638

 
9,726

 
17
 %
 
132,485

 
112,686

 
19,799

 
18
 %
Insurance expenses
28,192

 
26,513

 
1,679

 
6
 %
 
56,694

 
52,026

 
4,668

 
9
 %
Insurance commissions
3,881

 
4,132

 
(251
)
 
(6
)%
 
7,964

 
8,354

 
(390
)
 
(5
)%
Interest expense
8,552

 
8,793

 
(241
)
 
(3
)%
 
17,159

 
17,588

 
(429
)
 
(2
)%
Other operating expenses
42,293

 
45,030

 
(2,737
)
 
(6
)%
 
83,089

 
90,694

 
(7,605
)
 
(8
)%
Total benefits and expenses
255,390

 
236,540

 
18,850

 
8
 %
 
512,885

 
475,850

 
37,035

 
8
 %
Income from continuing operations before income taxes
75,740

 
66,950

 
8,790

 
13
 %
 
142,573

 
126,090

 
16,483

 
13
 %
Income taxes
26,469

 
23,782

 
2,687

 
11
 %
 
49,816

 
44,787

 
5,029

 
11
 %
Income from continuing operations
49,271

 
43,168

 
6,103

 
14
 %
 
92,757

 
81,303

 
11,454

 
14
 %
Income from discontinued operations, net of income taxes
$

 
$
322

 
(322
)
 
(100
)%
 
$
1,595

 
$
1,032

 
563

 
55
 %
Net income
$
49,271

 
$
43,490

 
$
5,781

 
13
 %
 
$
94,352

 
$
82,335

 
$
12,017

 
15
 %
Results for the Three and Six Months Ended June 30, 2014 and 2013
Total revenues. Total revenues for the three and six months ended June 30, 2014 compared to the three and six months ended June 30, 2013 increased primarily due to incremental premiums on term life insurance policies not


28


subject to the Citigroup reinsurance transactions, increased sales of investment products, and higher client asset values. Partially offsetting the increase was a decrease in realized investment gains related to large gains on tendered securities, as well as gains on certain sales of fixed maturity securities, in the prior year period.
Total benefits and expenses. Total benefits and expenses for the three and six months ended June 30, 2014 increased primarily as a result of the growth in revenue-related costs, which include sales commissions, benefits and claims, amortization of DAC, and certain insurance expenses. These higher expenses were partially offset by lower other operating expenses for the three and six months ended June 30, 2014, including lower legal fees and lower stock compensation costs due to the full vesting of IPO equity awards both in the prior year period.
Income taxes. Our effective income tax rate of 34.9% during the three and six months ended June 30, 2014 was lower compared with our effective income tax rate of 35.5% during the three and six months ended June 30, 2013 primarily due to the limited deductibility of certain IPO equity awards, which fully vested in April 2013.
For additional information, see the Segment Results discussions below.
Segment Results
Term Life Insurance Segment Results. Our results for the Term Life Insurance segment were as follows:
 
Three months ended June 30,
 
Change
 
Six months ended June 30,
 
Change
 
2014
 
2013
 
$
 
%
 
2014
 
2013
 
$
 
%
 
(Dollars in thousands)
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct premiums
$
567,848

 
$
559,035

 
$
8,813

 
2
 %
 
$
1,127,512

 
$
1,111,069

 
$
16,443

 
1
 %
Ceded premiums
(407,566
)
 
(414,222
)
 
(6,656
)
 
(2
)%
 
(807,900
)
 
(822,076
)
 
(14,176
)
 
(2
)%
Net premiums
160,282

 
144,813

 
15,469

 
11
 %
 
319,612

 
288,993

 
30,619

 
11
 %
Allocated net investment income
16,839

 
16,934

 
(95
)
 
(1
)%
 
33,552

 
33,604

 
(52
)
 
*

Other, net
7,245

 
7,435

 
(190
)
 
(3
)%
 
14,182

 
14,419

 
(237
)
 
(2
)%
Total revenues
184,366

 
169,182

 
15,184

 
9
 %
 
367,346

 
337,016

 
30,330

 
9
 %
Benefits and expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Benefits and claims
68,287

 
61,688

 
6,599

 
11
 %
 
139,551

 
127,235

 
12,316

 
10
 %
Amortization of DAC
29,778

 
25,777

 
4,001

 
16
 %
 
62,499

 
53,642

 
8,857

 
17
 %
Insurance commissions
929

 
1,062

 
(133
)
 
(13
)%
 
2,244

 
2,261

 
(17
)
 
(1
)%
Insurance expenses
26,293

 
24,508

 
1,785

 
7
 %
 
52,706

 
48,353

 
4,353

 
9
 %
Interest expense
4,009

 
4,250

 
(241
)
 
(6
)%
 
8,072

 
8,502

 
(430
)
 
(5
)%
Total benefits and expenses
129,296

 
117,285

 
12,011

 
10
 %
 
265,072

 
239,993

 
25,079

 
10
 %
Income from continuing operations before income taxes
$
55,070

 
$
51,897

 
$
3,173

 
6
 %
 
$
102,274

 
$
97,023

 
$
5,251

 
5
 %
_____________________
*
Less than 1%.
Results for the Three Months Ended June 30, 2014 and 2013
Net premiums. The increase in net premiums was primarily driven by the run-off of business subject to the Citigroup reinsurance transactions. Ceded premiums for this block are more than 80% of direct premiums. Ceded premiums supporting YRT reinsurance programs for new sales are a relatively low portion of direct premiums. As a result, as the proportion of direct premiums not subject to the Citigroup reinsurance transactions continues to grow, net premiums will continue to grow faster than direct premiums.
Allocated net investment income. Allocated net investment income remained flat year-over-year, as the higher allocation related to the growth in required assets was entirely offset by lower yield on invested assets.
Benefits and claims. Benefits and claims increased in line with the growth in net premiums.


29


Amortization of DAC. The increase in amortization of DAC was primarily attributable to an increased portion of commissions deferred in recent periods, resulting in a rate of DAC amortization in excess of the growth in net premiums, partially offset by improved persistency in the second quarter of 2014.
Insurance expenses. The increase in insurance expenses was mainly due to growth in the business and the run-off of Citigroup expense allowances.
Results for the Six Months Ended June 30, 2014 and 2013
Net premiums. Net premium growth was primarily driven by the factors impacting net premiums as discussed above in the three-month comparison.
Allocated net investment income. Allocated net investment income was relatively unchanged year-over-year as a result of the items discussed in the three-month comparison.
Benefits and claims. Benefits and claims increased primarily due to the growth in net premiums consistent with the discussion in the three-month comparison.
Amortization of DAC. The increase in amortization of DAC was primarily attributable to the increased portion of commissions deferred in recent periods as discussed above in the three-month comparison.
Insurance expenses. The increase in insurance expenses is mainly due to the factors discussed in the three-month comparison.
Product Sales and Face Amount In Force. We issued 59,569 new policies during the three months ended June 30, 2014 compared to 57,622 new policies for the same period in 2013. We issued 108,889 and 107,978 new policies during the six months ended June 30, 2014 and 2013, respectively. Sales of our term life insurance products increased during the six months ended June 30, 2014 primarily due to the modest gains in recruiting and licensing, partially offset by the impact of adverse weather conditions across North America in early 2014.
The changes in the face amount of our in force book of term life insurance policies were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
% of beginning balance
 
2013
 
% of beginning balance
 
2014
 
% of beginning balance
 
2013
 
% of beginning balance
 
(Dollars in millions)
Face amount in force, beginning of period
$
673,078

 
 
 
$
670,414

 

 
$
674,868

 
 
 
$
670,412

 

Net change in face amount:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Issued face amount
18,494

 
3%
 
17,798

 
3%
 
34,241

 
5%
 
33,507

 
5%
Terminations
(12,759
)
 
(2)%
 
(13,139
)
 
(2)%
 
(26,919
)
 
(4)%
 
(28,056
)
 
(4)%
Foreign currency
3,165

 
*
 
(718
)
 
*
 
(212
)
 
*
 
(1,508
)
 
*
Net change in face amount
8,900

 
1%
 
3,941

 
1%
 
7,110

 
1%
 
3,943

 
1%
Face amount in force, end of period
$
681,978

 
 
 
$
674,355

 

 
$
681,978

 
 
 
$
674,355

 

_____________________
*
Less than 1%.
For the three and six months ended June 30, 2014, issued face amount increased primarily due to the higher number of new policies issued. In addition, foreign currency exchange rates favorably impacted the face amount of in-force policies for the three months ended June 30, 2014. As a percentage of beginning face amount in force, issued face amount and terminations remained relatively flat during the three and six months ended June 30, 2014 compared to the prior year period.


30


Investment and Savings Product Segment Results. Investment and Savings Products segment results were as follows:
 
Three months ended June 30,
 
Change
 
Six months ended June 30,
 
Change
 
2014
 
2013
 
$
 
%
 
2014
 
2013
 
$
 
%
 
(Dollars in thousands)
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Commissions and fees:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales-based revenues
$
60,311

 
$
52,163

 
$
8,148

 
16
 %
 
$
118,274

 
$
101,881

 
$
16,393

 
16
 %
Asset-based revenues
56,058

 
49,436

 
6,622

 
13
 %
 
109,806

 
96,864

 
12,942

 
13
 %
Account-based revenues
9,957

 
9,589

 
368

 
4
 %
 
19,678

 
19,043

 
635

 
3
 %
Other, net
1,822

 
2,173

 
(351
)
 
(16
)%
 
3,660

 
4,295

 
(635
)
 
(15
)%
Total revenues
128,148

 
113,361

 
14,787

 
13
 %
 
251,418

 
222,083

 
29,335

 
13
 %
Expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Amortization of DAC
2,172

 
3,876

 
(1,704
)
 
(44
)%
 
4,507

 
6,768

 
(2,261
)
 
(33
)%
Insurance commissions
2,237

 
2,330

 
(93
)
 
(4
)%
 
4,324

 
4,605

 
(281
)
 
(6
)%
Sales commissions:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Sales-based
42,729

 
36,731

 
5,998

 
16
 %
 
84,323

 
72,134

 
12,189

 
17
 %
Asset-based
21,831

 
17,778

 
4,053

 
23
 %
 
42,526

 
34,415

 
8,111

 
24
 %
Other operating expenses
23,131

 
25,158

 
(2,027
)
 
(8
)%
 
45,663

 
50,320

 
(4,657
)
 
(9
)%
Total expenses
92,100

 
85,873

 
6,227

 
7
 %
 
181,343

 
168,242

 
13,101

 
8
 %
Income from continuing operations before income taxes
$
36,048

 
$
27,488

 
$
8,560

 
31
 %
 
$
70,075

 
$
53,841

 
$
16,234

 
30
 %
Supplemental information on the underlying metrics that drove results follows.
 
Three months ended June 30,
 
Change
 
Six months ended June 30,
 
Change
 
2014
 
2013
 
$
 
%
 
2014
 
2013
 
$
 
%
 
(Dollars in millions)
Product sales:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retail mutual funds
$
821

 
$
723

 
$
98

 
14
 %
 
$
1,642

 
$
1,435

 
$
207

 
14
 %
Annuities and other
502

 
473

 
29

 
6
 %
 
952

 
954

 
(2
)
 
*

Total sales-based revenue generating product sales
1,323

 
1,196

 
127

 
11
 %
 
2,594

 
2,389

 
205

 
9
 %
Managed accounts
65

 
58

 
7

 
12
 %
 
128

 
114

 
14

 
12
 %
Segregated funds and other
51

 
64

 
(13
)
 
(20
)%
 
128

 
180

 
(52
)
 
(29
)%
Total product sales
$
1,439

 
$
1,318

 
$
121

 
9
 %
 
$
2,850

 
$
2,683

 
$
167

 
6
 %
Average client asset values:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Retail mutual funds
$
29,829

 
$
26,041

 
$
3,788

 
15
 %
 
$
29,335

 
$
25,606

 
$
3,729

 
15
 %
Annuities and other
13,072

 
10,898

 
2,174

 
20
 %
 
12,875

 
10,603

 
2,272

 
21
 %
Managed accounts
1,203

 
786

 
417

 
53
 %
 
1,149

 
719

 
430

 
60
 %
Segregated funds
2,507

 
2,601

 
(94
)
 
(4
)%
 
2,478

 
2,613

 
(135
)
 
(5
)%
Total average client asset values
$
46,611

 
$
40,326

 
$
6,285

 
16
 %
 
$
45,837

 
$
39,541

 
$
6,296

 
16
 %
 
(Accounts in thousands)
Average number of fee-generating accounts:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Recordkeeping accounts
2,614

 
2,552

 
62

 
2
 %
 
2,601

 
2,529

 
72

 
3
 %
Custodial accounts
2,011

 
1,946

 
65

 
3
 %
 
2,001

 
1,943

 
58

 
3
 %
_____________________
*
Less than 1%.


31


Results for the Three Months Ended June 30, 2014 and 2013
Total revenues. The increase in commissions and fees was driven mostly by higher sales of mutual funds and variable annuities. The growth in sales-based revenues exceeded the increase in sales-based revenue generating product sales mainly due to the change in mix of annuity and other products sold from variable annuity internal exchanges and sales of group retirement accounts to product offerings with higher commission rates. The rise in average client asset values, which was indicative of favorable market performance and strong sales during the second quarter of 2014, also contributed to the increase in commissions and fees in the form of higher asset-based revenues.
Amortization of DAC. Our Canadian segregated funds benefited from favorable market performance, which resulted in lower DAC amortization for the three months ended June 30, 2014. Whereas, underperformance in Canadian markets in relation to our return expectations on client asset values resulted in higher DAC amortization in the prior year period.
Sales commissions. Higher sales-based commissions in the three months ended June 30, 2014 were primarily the result of the increase in product sales discussed above. The increase in asset-based commissions during the three months ended June 30, 2014 was consistent with the increase in asset-based revenues when excluding segregated funds. The relevant costs associated with asset-based revenue from segregated funds are recorded within insurance commissions and amortization of DAC.
Other operating expenses. Other operating expenses decreased primarily due to lower legal fees and expenses. Legal fees and expenses attributable to defending claims alleged by certain participants in the Florida Retirement System's benefit plan ("FRS") for the second quarter of 2014 and 2013 were approximately $0.3 million and $3.1 million, respectively. A settlement was reached in January 2014, which reduced the amount of legal fees and expenses incurred in association with this matter compared to the prior year period. See Note 11 (Commitments and Contingent Liabilities) to our unaudited condensed consolidated financial statements included elsewhere in this report for more information.
Results for the Six Months Ended June 30, 2014 and 2013
Total revenues. The increase in commissions and fees during the first six months of 2014 was driven mostly by the factors described in the three-month comparison.
Amortization of DAC. During the six months ended June 30, 2014, amortization of DAC decreased primarily due to the factors discussed above in the three-month comparison.
Sales commissions. Higher sales commissions in the six months ended June 30, 2014 resulted primarily from the items discussed in the three-month comparison.
Other operating expenses. Legal fees and expenses attributable to FRS were approximately $0.8 million and $7.0 million for the six months ended June 30, 2014 and 2013, respectively. Higher costs in support of our independent sales force and, to a lesser extent, higher employee compensation costs partially offset the favorable impact of the lower FRS-related costs in the first half of 2014.
Asset Values in Client Accounts
Changes in asset values in client accounts were as follows:
 
Three months ended June 30,
 
Six months ended June 30,
 
2014
 
% of beginning balance
 
2013
 
% of beginning balance
 
2014
 
% of beginning balance
 
2013
 
% of beginning balance
 
(Dollars in millions)
Asset values, beginning of period
$
45,839

 
 
 
$
39,853

 

 
$
44,990

 
 
 
$
37,386

 

Net change in asset values:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Inflows
1,439

 
3%
 
1,318

 
3%
 
2,850

 
6%
 
2,683

 
7%
Redemptions
(1,211
)
 
(3)%
 
(1,188
)
 
(3)%
 
(2,457
)
 
(5)%
 
(2,493
)
 
(7)%
Change in market value, net and other
1,941

 
4%
 
183

 
*
 
2,625

 
6%
 
2,590

 
7%
Net change in asset values
2,169

 
5%
 
313

 
1%
 
3,018

 
7%
 
2,780

 
7%
Asset values, end of period
$
48,008

 
 
 
$
40,166

 

 
$
48,008

 
 
 
$
40,166

 

_____________________
*
Less than 1%.


32


The increase in asset values for three and six months ended June 30, 2014 was primarily attributable to favorable market performance. As a percentage of beginning asset values, the growth in inflows and the rate of redemptions relative to average client asset values for the three and six months ended June 30, 2014 remained consistent with the prior year period.
Corporate and Other Distributed Products Segment Results. Corporate and Other Distributed Products segment results were as follows:
 
Three months ended June 30,
 
Change
 
Six months ended June 30,
 
Change
 
2014
 
2013
 
$
 
%
 
2014
 
2013
 
$
 
%
 
(Dollars in thousands)
Revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Direct premiums
$
8,892

 
$
9,356

 
$
(464
)
 
(5
)%
 
$
17,433

 
$
18,226

 
$
(793
)
 
(4
)%
Ceded premiums
(2,980
)
 
(3,228
)
 
(248
)
 
(8
)%
 
(5,361
)
 
(5,978
)
 
(617
)
 
(10
)%
Net premiums
5,912

 
6,128

 
(216
)
 
(4
)%
 
12,072

 
12,248

 
(176
)
 
(1
)%
Commissions and fees
5,713

 
5,994

 
(281
)
 
(5
)%
 
11,212

 
11,667

 
(455
)
 
(4
)%
Allocated net investment income
4,842

 
4,093

 
749

 
18
 %
 
9,728

 
10,639

 
(911
)
 
(9
)%
Realized investment gains (losses), including other-than-temporary impairment losses
831

 
3,468

 
(2,637
)
 
(76
)%
 
1,094

 
5,754

 
(4,660
)
 
(81
)%
Other, net
1,318

 
1,264

 
54

 
4
 %
 
2,588

 
2,533

 
55

 
2
 %
Total revenues
18,616

 
20,947

 
(2,331
)
 
(11
)%
 
36,694

 
42,841

 
(6,147
)
 
(14
)%
Benefits and expenses:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Benefits and claims
4,125

 
2,634

 
1,491

 
57
 %
 
8,053

 
5,903

 
2,150

 
36
 %
Amortization of DAC
746

 
459

 
287

 
63
 %
 
884

 
954

 
(70
)
 
(7
)%
Insurance commissions
715

 
740

 
(25
)
 
(3
)%
 
1,396

 
1,488

 
(92
)
 
(6
)%
Insurance expenses
1,899

 
2,005

 
(106
)
 
(5
)%
 
3,988

 
3,673

 
315

 
9
 %
Sales commissions
2,804

 
3,129

 
(325
)
 
(10
)%
 
5,636

 
6,137

 
(501
)
 
(8
)%
Interest expense
4,543

 
4,543

 

 
 %
 
9,087

 
9,086

 
1

 
*

Other operating expenses
19,162

 
19,872

 
(710
)
 
(4
)%
 
37,426

 
40,374

 
(2,948
)
 
(7
)%
Total benefits and expenses
33,994

 
33,382

 
612

 
2
 %
 
66,470

 
67,615

 
(1,145
)
 
(2
)%
Loss from continuing operations before income taxes
$
(15,378
)
 
$
(12,435
)
 
$
2,943

 
24
 %
 
$
(29,776
)
 
$
(24,774
)
 
$
5,002

 
20
 %
_____________________
*
Less than 1%.
Results for the Three Months Ended June 30, 2014 and 2013
Total revenues. Total revenues decreased for the three months ended June 30, 2014 primarily due to lower realized investment gains, partially offset by higher net investment income. Realized investment gains decreased year-over-year mostly due to higher income received from certain fixed income securities that were tendered during the prior year period. The increase in net investment income was attributable to the increase in market value of the deposit asset underlying our 10% Coinsurance Agreement, partially offset by lower average base of invested assets and lower average yield on invested assets.
Total benefits and expenses. Total benefits and expenses were marginally higher for the three months ended June 30, 2014 compared to the prior year period mostly due to higher benefits and claims attributable to an increase in claims on non-term life insurance policies underwritten by our New York subsidiary.
Results for the Six Months Ended June 30, 2014 and 2013
Total revenues. Total revenues decreased for the six months ended June 30, 2014 primarily due to the factors noted in the three-month comparison. In addition, the decline in net investment income for the six months ended June 30,


33


2014 was primarily attributable to a higher allocation to the Term Life segment, lower average base of invested assets, and lower average yield on invested assets, partially offset by the rise in market value of the deposit asset underlying our 10% Coinsurance Agreement.
Total benefits and expenses. The decrease in benefits and expenses during the six months ended June 30, 2014 was primarily due to lower operating expenses attributable to lower stock compensation costs related to the full vesting of restricted stock granted in connection with our IPO. This decrease was partially offset by an increase in benefits and claims attributable to the factors noted in the three-month comparison.

Financial Condition
Investments. We have an investment committee composed of members of our senior management team that is responsible for establishing and maintaining our investment guidelines and supervising our investment activity. We follow a conservative investment strategy designed to emphasize the preservation of our invested assets and provide adequate liquidity for the prompt payment of claims. To meet business needs and mitigate risks, our investment guidelines provide restrictions on our portfolio’s composition, including limits on asset type, sector limits, credit quality limits, portfolio duration, limits on the amount of investments in approved countries and permissible security types. Additionally, to ensure adequate liquidity for payment of claims, we take into account the maturity and duration of our invested asset portfolio and our general liability profile.
Our invested asset portfolio is subject to a variety of risks, including risks related to general economic conditions, market volatility, interest rate fluctuations, liquidity risk and credit and default risk. Investment guideline restrictions have been established to minimize the effect of these risks but may not always be effective due to factors beyond our control. Interest rates are highly sensitive to many factors, including governmental monetary policies, domestic and international economic and political conditions and other factors beyond our control. A significant increase in interest rates could result in significant losses, realized or unrealized, in the value of our invested asset portfolio.
The composition and duration of our portfolio will vary depending on several factors, including the yield curve and our opinion of the relative value among various asset classes. The average rating and average approximate duration of our fixed-maturity portfolio were as follows:
 
June 30, 2014
 
December 31, 2013
Average rating of our fixed-maturity portfolio
 A
 
A
Average duration of our fixed-maturity portfolio
4.3 years
 
4.0 years
Average book yield of our fixed-maturity portfolio
4.76%
 
4.93%
The distribution of our investments in fixed-maturity securities by rating follows:
 
June 30, 2014
 
December 31, 2013
 
Amortized cost
 
%
 
Amortized cost
 
%
 
(Dollars in thousands)
AAA
$
286,504

 
17%
 
$
296,717

 
18%
AA
139,940

 
8%
 
133,406

 
8%
A
374,666

 
22%
 
386,460

 
23%
BBB
802,137

 
48%
 
777,111

 
46%
Below investment grade
82,267

 
5%
 
80,835

 
5%
Not rated
507

 
*
 
1,484

 
*
Total
$
1,686,021

 
100%
 
$
1,676,013

 
100%
____________________
*
Less than 1%.


34


The ten largest holdings within our invested asset portfolio were as follows:
 
June 30, 2014
Issuer
Fair
 value
 
Cost or amortized
cost
 
Unrealized
gain
 
Credit
rating
 
(Dollars in thousands)
Government of Canada
$
29,654

 
$
28,684

 
$
970

 
 AAA
General Electric Co
26,931

 
23,892

 
3,039

 
 AA-
Province of Ontario Canada
11,633

 
10,398

 
1,235

 
 AA-
Washington Real Estate Investment
11,055

 
10,528

 
527

 
 BBB
Iberdrola SA
10,501

 
9,468

 
1,033

 
 BBB+
National Rural Utilities Cooperative
9,932

 
7,470

 
2,462

 
 A+
International Business Machines Corp
9,791

 
9,145

 
646

 
 AA-
Wells Fargo & Co
8,885

 
8,387

 
498

 
 A
Enel SpA
7,860

 
6,982

 
878

 
 BBB
ArcelorMittal
7,851

 
6,611

 
1,240

 
 BB+
Total – ten largest holdings
$
134,093

 
$
121,565

 
$
12,528

 
 
Total – fixed-maturity and equity securities
$
1,863,835

 
$
1,725,374

 
 
 
 
Percent of total fixed-maturity and equity securities
7
%
 
7
%
 
 
 
 
For additional information on our invested asset portfolio, see Note 4 (Investments) to our unaudited condensed consolidated financial statements included elsewhere in this report.

Liquidity and Capital Resources
Dividends and other payments to the Parent Company from our subsidiaries are our principal sources of cash. The amount of dividends paid by our subsidiaries is dependent on their capital needs to fund future growth and applicable regulatory restrictions. The primary uses of funds by the Parent Company include the payments of general operating expenses, income taxes, stockholder dividends, and interest on outstanding debt, as well as repurchases of shares outstanding. At June 30, 2014, the Parent Company had cash and invested assets of approximately $48.9 million.
Our subsidiaries generate operating cash flows primarily from term life insurance premiums (net of premiums ceded to reinsurers), income from invested assets, commissions and fees collected from the distribution of investment and savings products as well as other financial products. Our subsidiaries' principal operating cash outflows include the payment of insurance claims and benefits (net of ceded claims recovered from reinsurers), commissions to our sales force, insurance and other operating expenses, interest expense for future policy benefit reserves financing transactions, and income taxes.
The distribution and underwriting of term life insurance requires upfront cash outlays at the time the policy is issued as we pay a substantial majority of the sales commission during the first year following the sale of a policy and incur costs for underwriting activities at the inception of a policy’s term. During the early years of a policy's term, we generally receive level term premiums in excess of claims paid. We invest the excess cash generated during earlier policy years in fixed-maturity and equity securities held in support of future policy benefit reserves. In later policy years, cash received from the maturity or sale of invested assets is used to pay claims in excess of level term premiums received.
Historically, cash flows generated by our businesses, primarily from our existing block of term life policies and our investment and savings products, have provided our consolidated entities with sufficient liquidity to meet their operating requirements. We anticipate that cash flows from our businesses will continue to provide sufficient operating liquidity over the next 12 months.
We may seek to enhance our liquidity position or capital structure through borrowings from third-party sources, sales of debt or equity securities, reserve financings or some combination of these sources. Additionally, we believe that cash flows from our businesses and potential sources of funding, as described above, will sufficiently support the long-term liquidity needs of the Parent Company and our subsidiaries.


35


Cash Flows. The components of the change in cash and cash equivalents were as follows:
 
Six months ended June 30,
 
Change
 
2014
 
2013
 
$
 
(In thousands)
Net cash provided by (used in) operating activities
$
70,454

 
$
52,504

 
$
17,950

Net cash provided by (used in) investing activities
(17,405
)
 
129,544

 
(146,949
)
Net cash provided by (used in) financing activities
(51,174
)
 
(175,087
)
 
123,913

Effect of foreign exchange rate changes on cash
(443
)
 
(1,090
)
 
647

Change in cash and cash equivalents
$
1,432

 
$
5,871

 
$
(4,439
)
Operating Activities. The increase in operating cash flows for the six months ended June 30, 2014 was largely driven by lower cash payments of income taxes, receipts of premiums in excess of claims paid, and net proceeds from sales and maturities of trading securities. Partially offsetting this increase was the impact of timing of payments with reinsurers in our Term Life business and payments for settlements and other related costs for FRS.
Investing Activities. The decrease in investing cash inflows was primarily driven by lower purchases of fixed-maturity securities in the prior year period, as we accumulated cash to fund the $154.7 million repurchase of common stock and outstanding warrants in June 2013 from certain private equity funds managed by Warburg Pincus LLC. The decrease was partially offset by lower purchases of property and equipment in the first half of 2014 primarily attributable to asset purchases related to the move of our corporate headquarters in the prior year period.
Financing Activities. Net cash used in financing activities was lower for the first half of 2014 compared to the prior year period primarily due to lower repurchases of our common stock and outstanding warrants. Share repurchases in 2014 were made in the open market under our current share repurchase program, while the share and warrant repurchases made in 2013 consisted primarily of the $154.7 million repurchase in June 2013.
Risk-Based Capital. The National Association of Insurance Commissioners has established risk-based capital (“RBC”) standards for U.S. life insurers, as well as a risk-based capital model act (the “RBC Model Act”) that has been adopted by the insurance regulatory authorities. The RBC Model Act requires that life insurers annually submit a report to state regulators regarding their RBC based upon four categories of risk: asset risk; insurance risk; interest rate risk; and business risk. The capital requirement for each is determined by applying factors that vary based upon the degree of risk to various asset, premiums and policy benefit reserve items. The formula is an early warning tool to identify possible weakly capitalized companies for purposes of initiating further regulatory action.
As of June 30, 2014, our U.S. life insurance subsidiaries had statutory capital substantially in excess of the applicable statutory requirements to support existing operations and to fund future growth.
In Canada, an insurer’s minimum capital requirement is overseen by the Office of the Superintendent of Financial Institutions Canada (“OSFI”) and determined as the sum of the capital requirements for five categories of risk: asset default risk; mortality/morbidity/lapse risks; changes in interest rate environment risk; segregated funds risk; and foreign exchange risk. Primerica Life Canada is in compliance with Canada’s minimum capital requirements as of June 30, 2014, as determined by OSFI.
Redundant Reserve Financings. The Model Regulation entitled Valuation of Life Insurance Policies, commonly known as Regulation XXX, requires insurers to carry statutory policy benefit reserves for term life insurance policies with long-term premium guarantees which are often significantly in excess of the future policy benefit reserves that insurers deem necessary to satisfy claim obligations ("redundant policy benefit reserves"). Accordingly, many insurance companies have sought ways to reduce their capital needs by financing redundant policy benefit reserves through bank financing, reinsurance arrangements and other financing transactions.
In March 2012, Peach Re, Inc. ("Peach Re"), a special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life, and Primerica Life entered into a Regulation XXX redundant reserve financing transaction to more efficiently manage and deploy our capital. For information on this transaction, see Note 11 (Commitments and Contingent Liabilities) to our unaudited condensed consolidated financial statements included elsewhere in this report.
In July 2014, Vidalia Re, Inc. ("Vidalia Re"), a newly formed special purpose financial captive insurance company and wholly owned subsidiary of Primerica Life, and Primerica Life entered into a Regulation XXX redundant reserve financing transaction to more efficiently manage and deploy our capital. For more information on this redundant


36


reserve financing transaction, see Note 12 (Subsequent Events) to our unaudited condensed consolidated financial statements included elsewhere in this report.
Notes Payable. The Company has $375.0 million of publicly-traded, senior unsecured notes outstanding at a price of 99.843% and an annual rate of 4.75%, payable semi-annually in arrears on January 15 and July 15. The Senior Notes mature July 15, 2022.
We were in compliance with the covenants of the Senior Notes at June 30, 2014. No events of default occurred during the six months ended June 30, 2014.
We calculate our debt-to-capital ratio by dividing total long-term debt by the sum of stockholders’ equity and total long-term debt. As of June 30, 2014, our debt-to-capital ratio was 22.3%.
Rating Agencies. There have been no changes to Primerica, Inc.'s senior debt ratings or Primerica Life's financial strength ratings since December 31, 2013.
Short-term Borrowings. We had no short-term borrowings as of or during the six months ended June 30, 2014.
Off-Balance Sheet Arrangements. Our off-balance sheet arrangements as of June 30, 2014 consisted of the letter of credit issued under the credit facility agreement with Deutsche Bank as described in Note 11 (Commitments and Contingent Liabilities) to our unaudited condensed consolidated financial statements included elsewhere in this report.
Contractual Obligations Update. There have been no material changes in contractual obligations from those disclosed in the 2013 Annual Report.

CAUTIONARY STATEMENT CONCERNING FORWARD-LOOKING STATEMENTS
Investors are cautioned that certain statements contained in this report as well as some statements in periodic press releases and some oral statements made by our officials during our presentations are “forward-looking” statements. Forward-looking statements include, without limitation, any statement that may project, indicate or imply future results, events, performance or achievements, and may contain the words “expect,” “intend,” “plan,” “anticipate,” “estimate,” “believe,” “will be,” “will continue,” “will likely result,” and similar expressions, or future conditional verbs such as “may,” “will,” “should,” “would,” and “could.” In addition, any statement concerning future financial performance (including future revenues, earnings or growth rates), ongoing business strategies or prospects, and possible actions taken by us or our subsidiaries are also forward-looking statements. These forward-looking statements involve external risks and uncertainties, including, but not limited to, those described under the section entitled “Risk Factors” included herein.
Forward-looking statements are based on current expectations and projections about future events and are inherently subject to a variety of risks and uncertainties, many of which are beyond the control of our management team. All forward-looking statements in this report and subsequent written and oral forward-looking statements attributable to us, or to persons acting on our behalf, are expressly qualified in their entirety by these risks and uncertainties. These risks and uncertainties include, among others:
our failure to continue to attract and license new recruits, retain sales representatives, or license or maintain the licensing of our sales representatives;
changes to the independent contractor status of our sales representatives;
our or our sales representatives' violation of, or non-compliance with, laws and regulations;
our or our sales representatives' failure to protect the confidentiality of client information;
differences between our actual experience and our expectations regarding mortality, persistency, expenses and investment yields as reflected in the pricing for our insurance policies;
the occurrence of a catastrophic event that causes a large number of premature deaths of our insureds;
changes in federal and state legislation and regulation, including other legislation or regulation that affects our insurance and investment product businesses;
our failure to meet risk-based capital standards or other minimum capital or surplus requirements;
a downgrade or potential downgrade in our insurance subsidiaries' financial strength ratings or in the investment grade credit ratings for our senior unsecured debt;
the effects of credit deterioration and interest rate fluctuations on our invested asset portfolio;


37


incorrectly valuing our investments;
inadequate or unaffordable reinsurance or the failure of our reinsurers to perform their obligations;
the failure of, or legal challenges to, the support tools we provide to our sales force;
heightened standards of conduct or more stringent licensing requirements for our sales representatives;
inadequate policies and procedures regarding suitability review of client transactions;
the inability of our subsidiaries to pay dividends or make distributions;
our ability to generate and maintain a sufficient amount of working capital;
our non-compliance with the covenants of our senior unsecured debt;
legal and regulatory investigations and actions concerning us or our sales representatives;
the loss of key personnel;
the failure of our information technology systems, breach of our information security or failure of our business continuity plan; and
fluctuations in Canadian currency exchange rates.
Developments in any of these areas could cause actual results to differ materially from those anticipated or projected or cause a significant reduction in the market price of our common stock and debt securities.
The foregoing list of risks and uncertainties may not contain all of the risks and uncertainties that could affect us. In addition, in light of these risks and uncertainties, the matters referred to in the forward-looking statements contained in this document may not in fact occur. Accordingly, undue reliance should not be placed on these statements. We undertake no obligation to publicly update or revise any forward-looking statements as a result of new information, future events or otherwise, except as otherwise required by law.

ITEM 3. QUANTITATIVE AND QUALITATIVE DISCLOSURES ABOUT MARKET RISK.
There have been no material changes in our exposures to market risk since December 31, 2013. For details on the Company's interest rate, foreign currency exchange, and credit risks, see "Item 7A. Quantitative and Qualitative Information About Market Risks" in our 2013 Annual Report.

ITEM 4. CONTROLS AND PROCEDURES.
Disclosure Controls and Procedures
The Company’s management, with the participation of the Company’s Co-Chief Executive Officers and Chief Financial Officer, has evaluated the effectiveness of the Company’s disclosure controls and procedures (as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange Act”)) as of the end of the period covered by this quarterly report (the “Evaluation Date”). Based on such evaluation, the Company’s Co-Chief Executive Officers and Chief Financial Officer have concluded that, as of the Evaluation Date, the Company’s disclosure controls and procedures are effective.
Changes in Internal Control Over Financial Reporting
There have not been any changes in the Company’s internal control over financial reporting (as such term is defined in Rules 13a-15(f) and 15d-15(f) under the Exchange Act) during the second quarter of 2014 that have materially affected, or are reasonably likely to materially affect, the Company's internal control over financial reporting.


38


PART II – OTHER INFORMATION

ITEM 1. LEGAL PROCEEDINGS.
We are involved from time to time in legal disputes, regulatory inquiries and arbitration proceedings in the normal course of business. Additional information regarding certain legal proceedings to which we are a party is described in Note 11 (Commitments and Contingent Liabilities) to our unaudited condensed consolidated financial statements and such information is incorporated herein by reference. As of the date of this report, other than as discussed in the paragraph below, we do not believe any pending legal proceeding to which Primerica or any of its subsidiaries is a party is required to be disclosed pursuant to this item.
Between July 4, 2014 and July 7, 2014, we issued Applications in the Ontario Superior Court of Justice naming as the Respondents the Financial Services Commission of Ontario and the government of Ontario. On July 24, 2014, we issued an Application in the Court of Queen's Bench for Saskatchewan naming as Respondents the Insurance Councils of Saskatchewan and Life Insurance Council of Saskatchewan. The Applications seek a declaration that a Memorandum of Understanding and related agreements entered into by the insurance regulators of the Canadian provinces and territories to implement a new life insurance licensing examination program across Canada in early 2016 are null and void and of no force and effect. See "Item 1A. Risk Factors." for more information.

ITEM 1A. RISK FACTORS.
The following supplements and amends the Risk Factors contained in our Annual Report on Form 10-K for the year ended December 31, 2013, which are incorporated herein by reference.
Our failure to continue to attract new recruits, retain sales representatives or license or maintain the licensing of our sales representatives would materially adversely affect our business, financial condition and results of operations.
New sales representatives provide us with access to new clients, enable us to increase sales and provide the next generation of successful sales representatives. As is typical with distribution businesses, we experience a high rate of turnover among our part-time sales representatives, which requires us to attract, retain and motivate a large number of sales representatives. Recruiting is performed by our current sales representatives, and the effectiveness of our recruiting is generally dependent upon our reputation as a provider of a rewarding and potentially lucrative income opportunity, as well as the general competitive and economic environment. Whether recruits are motivated to complete their training and licensing requirements and to commit to selling our products is largely dependent upon the effectiveness of our compensation and promotional programs and the competitiveness of such programs compared with other companies, including other part-time business opportunities.
If our new business opportunities and products do not generate sufficient interest to attract new recruits, motivate them to become licensed sales representatives and maintain their licenses and incentivize them to sell our products and recruit other new sales representatives, our business would be materially adversely affected.
Certain of our key RVPs have large sales organizations that include thousands of downline sales representatives. These key RVPs are responsible for attracting, motivating, supporting and assisting the sales representatives in their sales organizations. The loss of one or more key RVPs together with a substantial number of their sales representatives for any reason could materially adversely affect our financial results and could impair our ability to attract new sales representatives.
Furthermore, if we or any other businesses with a similar distribution structure engage in practices resulting in increased negative public attention for our business model, the resulting reputational challenges could adversely affect our ability to attract new recruits. Companies such as ours that use independent agents to sell directly to customers can be the subject of negative commentary on website postings, social media and other non-traditional media. This negative commentary can spread inaccurate or incomplete information about distribution companies in general or our company in particular, which can make our recruiting more difficult.
From time to time, various jurisdictions make changes to the state or provincial licensing examination process that may make it more difficult for our sales representatives to obtain their life insurance licenses. The insurance regulators in the Canadian provinces and territories entered into a Memorandum of Understanding and related agreements to implement a new life insurance licensing examination program across Canada in early 2016. If this


39


new licensing program is implemented under the terms set forth in the agreements, we believe it would significantly decrease the ability of applicants to obtain their life insurance licenses in Canada. At this time, we cannot quantify the impact of the new licensing program on us. However, we believe the program could result in a significant decline in the number of our new life-licensed representatives in Canada and ultimately the size of our life-licensed sales force. This could lower new life insurance sales and over time lower the size of our in-force life insurance premium and materially adversely affect our Canadian Term Life insurance business. Between July 4, 2014 and July 7, 2014, we issued Applications in the Ontario Superior Court of Justice naming as the Respondents the Financial Services Commission of Ontario and the government of Ontario. On July 24, 2014, we issued an Application in the Court of Queen's Bench for Saskatchewan naming as Respondents the Insurance Councils of Saskatchewan and Life Insurance Council of Saskatchewan. The Applications seek a declaration that the Memorandum of Understanding and related agreements are null and void and of no force and effect.

ITEM 2. UNREGISTERED SALES OF EQUITY SECURITIES AND USE OF PROCEEDS.
During the quarter ended June 30, 2014, we repurchased shares of our common stock as follows:
Period
 
Total number of shares purchased(1)
 
Average price paid per share(1)
 
Total number of shares purchased as part of publicly announced plans or programs
 
Approximate dollar value of shares that may yet be purchased under the plans or programs
April 1 - 30, 2014
 
255,635

 
$
46.11

 
255,238

 
$
125,166,624

May 1 - 31, 2014
 
107,938

 
44.05

 
107,938

 
120,412,070

June 1 - 30, 2014
 
117,898

 
46.06

 
117,726

 
114,989,205

     Total
 
481,471

 
$
45.63

 
480,902

 
$
114,989,205

____________________
(1) 
Consists of (a) repurchases of 569 shares at an average price of $45.90 arising from share-based compensation tax withholdings and stock option exercises and (b) open market repurchases of shares under the share repurchase program approved by our Board of Directors.
For information regarding year-to-date share repurchases, refer to Note 8 (Stockholders' Equity) to our unaudited condensed consolidated financial statements included elsewhere in this report.

ITEM 6. EXHIBITS.
The agreements included as exhibits to this report are included to provide you with information regarding the terms of these agreements and are not intended to provide any other factual or disclosure information about the Company or its subsidiaries, our business or the other parties to these agreements. These agreements may contain representations and warranties by each of the parties to the applicable agreement. These representations and warranties have been made solely for the benefit of the other parties to the applicable agreement and:
should not in all instances be treated as categorical statements of fact, but rather as a way of allocating the risk to one of the parties if those statements prove to be inaccurate;
have been qualified by disclosures that were made to the other party in connection with the negotiation of the application agreement, which disclosures are not necessarily reflected in the agreement;
may apply standards of materiality in a way that is different from what may be viewed as material to our investors; and
were made only as of the date of the applicable agreement or such other date or dates as may be specified in the agreement and are subject to more recent developments.
Accordingly, these representations and warranties may not describe the actual state of affairs as of the date they were made or at any other time, and should not be relied upon by investors.


40


Exhibit
Number
  
Description
 
Reference
3.1
  
Amended and Restated Certificate of Incorporation of the Registrant.
 
Incorporated by reference to Exhibit 3.1 to Primerica's Current Report on Form 8-K dated May 22, 2013 (Commission File No. 001-34680).
3.2
  
Amended and Restated Bylaws of the Registrant.
 
Incorporated by reference to Exhibit 3.2 to Primerica's Current Report on Form 8-K dated May 22, 2013 (Commission File No. 001-34680).
4.1
 
Indenture, dated July 16, 2012, among the Registrant and Wells Fargo Bank, National Association, as trustee.
 
Incorporated by reference to Exhibit 4.1 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
4.2
 
First Supplemental Indenture, dated July 16, 2012, among the Registrant and Wells Fargo Bank, National Association, as trustee.
 
Incorporated by reference to Exhibit 4.2 to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
4.3
 
Form of 4.750% Senior Notes due 2022.
 
Incorporated by reference to Exhibit 4.3 (included in Exhibit 4.2 filed herewith) to Primerica's Current Report on Form 8-K dated July 11, 2012 (Commission File No. 001-34680).
31.1
  
Rule 13a-14(a)/15d-14(a) Certification, executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer.
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
31.2
  
Rule 13a-14(a)/15d-14(a) Certification, executed by John A. Addison, Chairman of Primerica Distribution and Co-Chief Executive Officer.
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
31.3
  
Rule 13a-14(a)/15d-14(a) Certification, executed by Alison S. Rand, Executive Vice President and Chief Financial Officer.
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
32.1
  
Certifications required by Rule 13a-14(b) or Rule 15d-14(b) and Section 1350 of Chapter 63 of Title 18 of the United States Code (18 U.S.C. 1350), executed by D. Richard Williams, Chairman of the Board and Co-Chief Executive Officer, John A. Addison, Chairman of Primerica Distribution and Co-Chief Executive Officer, and Alison S. Rand, Executive Vice President and Chief Financial Officer.
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
101.INS
 
XBRL Instance Document(1)
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
101.SCH
 
XBRL Taxonomy Extension Schema
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
101.CAL
 
XBRL Taxonomy Extension Calculation Linkbase
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
101.DEF
 
XBRL Taxonomy Extension Definition Linkbase
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
101.LAB
 
XBRL Taxonomy Extension Label Linkbase
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
101.PRE
 
XBRL Taxonomy Extension Presentation Linkbase
 
Filed with the Securities and Exchange Commission as part of this Quarterly Report.
____________________
(1) 
Includes the following materials contained in this Quarterly Report on Form 10-Q for the period ended June 30, 2014, formatted in XBRL: (i) Condensed Consolidated Balance Sheets, (ii) Condensed Consolidated Statements of Income, (iii) Condensed Consolidated Statements of Comprehensive Income, (iv) Condensed Consolidated Statements of Stockholders’ Equity, (v) Condensed Consolidated Statements of Cash Flows, and (vi) Notes to Condensed Consolidated Financial Statements.



41


SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized.
 
 
 
Primerica, Inc.
 
 
August 7, 2014
/s/ Alison S. Rand
 
Alison S. Rand
 
Executive Vice President and Chief Financial Officer
(Principal Financial and Accounting Officer)



42